Speeches made during Parliamentary debates are recorded in Hansard. For ease of browsing we have grouped debates into individual, departmental and legislative categories.
e-Petitions are administered by Parliament and allow members of the public to express support for a particular issue.
If an e-petition reaches 10,000 signatures the Government will issue a written response.
If an e-petition reaches 100,000 signatures the petition becomes eligible for a Parliamentary debate (usually Monday 4.30pm in Westminster Hall).
These initiatives were driven by Chi Onwurah, and are more likely to reflect personal policy preferences.
MPs who are act as Ministers or Shadow Ministers are generally restricted from performing Commons initiatives other than Urgent Questions.
Chi Onwurah has not introduced any legislation before Parliament
Football Regulation Bill 2017-19
Sponsor - Christian Matheson (LAB)
I met with the chair of the Climate Change Committee following the publication of the report.
The Cabinet’s Climate Action Implementation Committee, which I chair, has also had an initial discussion on the findings of the report.
The Government will set out a formal response later this year.
In its recently published Strategic Plan 2022 to 2025, the Equality and Human Rights Commission singled out digital services and artificial intelligence as one of its strategic priorities. The Commission intends to intervene where necessary to ensure that people are protected from discrimination online, just as they must be in more traditional settings.
We must draw on all our available talent and inspire more young people, including those currently under-represented in the STEM workforce, to take up STEM subjects and careers. Our focus on STEM diversity is primarily because of its importance to the UK's continued growth and its impact on wider society. STEM sector jobs are, on average, higher paid than those in the retail and care sectors, so supporting under-represented people into STEM helps their income, and supports our levelling up agenda.
The Equality Hub’s focus is on data and evidence, and a commitment to sharing that across Government so that we can all develop practical interventions that we know will have an impact. Officials work closely with other relevant departments, as well as academics and other organisations working in the sector to improve the shared evidence base.
The Social Mobility Commission (SMC), an independent body sponsored by the Equality Hub in the Cabinet Office, looks at social mobility from a UK perspective. The Social Mobility Commission's new Index does not focus on any one sector or industry, but looks at occupational classes more broadly, using the NS-SEC classifications from the ONS Labour Force Survey.
The Government is carefully considering the findings of the independent Commission on Race and Ethnic Disparities report and will publish its response in due course.
In line with the Commission’s findings, the Department for Digital, Culture, Media and Sport (DCMS) published a consultation in September 2021 examining the role of sensitive personal data in bias detection and mitigation in AI systems, and the use of the term ‘fairness’ in a data protection context. The consultation is now closed and DCMS is analysing the responses.
The National AI Strategy published in September 2021 also sets out further government action to address concerns around fairness and algorithmic bias. The strategy can be found here: https://www.gov.uk/government/publications/national-ai-strategy/national-ai-strategy-html-version.
We take this issue very seriously. On Monday my Rt Hon. friend the Secretary of State for Health and Social Care announced a review into possible inadvertent bias in medical devices. The Equality and Human Rights Commission has also set tackling the challenges faced by AI as one of the priority work areas in its draft strategic plan for the next three years. It is engaging with key stakeholders in AI, like the Ada Lovelace Institute and the Alan Turing Institute and is developing guidance on AI and the Public Sector Equality Duty, for government departments and public bodies, which will be published early in the new year.
The Equality Act 2010 (the Act) prohibits employers and service providers from discriminating against employees, job applicants and customers because of or in relation to a protected characteristic. This includes discrimination through actions taken as a result of deploying an algorithm or a similar artificial intelligence mechanism. The key test is how the employer or service provider acts and whether this is lawful under the Act, not the tools used in the decision-making process.
It is for the courts to interpret and apply the law, including where new and evolving technology is at play. To date, it has not been necessary to consider amendments to the Equality Act 2010 in this context and the Government has no plans to bring forward such legislation. However, we will continue to monitor developments.
On 10 September 2021 the government launched a public consultation, Data: A new direction. The consultation proposes reforms to enable organisations to use personal data and sensitive personal data for the purpose of managing the risk of bias in their AI systems. The consultation will close on 19 November 2021.
In addition, the Equality and Human Rights Commission is developing guidance for the public sector on algorithmic decision-making.
The independent Commission on Race and Ethnic Disparities published its findings on 31 March 2021. The report took an evidence-led approach drawing on academic research, expert views and over 2,300 submissions to the call for evidence. The Employment and Enterprise chapter of the report summarises the Commission’s research about Artificial Intelligence systems and bias in technology.
The Commission recommended that the government issue guidance that clarifies how to apply the Equality Act to algorithmic decision-making and require transparency for public sector bodies when this is applied to decisions concerning individuals. The government is still carefully considering the report’s findings and recommendations and will respond in full this summer.
The independent Commission on Race and Ethnic Disparities published its findings on 31 March 2021. The report took an evidence-led approach drawing on academic research, expert views and over 2,300 submissions to the call for evidence. The Employment and Enterprise chapter of the report summarises the Commission’s research about Artificial Intelligence systems and bias in technology.
The Commission recommended that the government issue guidance that clarifies how to apply the Equality Act to algorithmic decision-making and require transparency for public sector bodies when this is applied to decisions concerning individuals. The government is still carefully considering the report’s findings and recommendations and will respond in full this summer.
The independent Commission on Race and Ethnic Disparities published its findings on 31 March 2021. The report took an evidence-led approach drawing on academic research, expert views and over 2,300 submissions to the call for evidence. The Employment and Enterprise chapter of the report summarises the Commission’s research about Artificial Intelligence systems and bias in technology.
The Commission recommended that the government issue guidance that clarifies how to apply the Equality Act to algorithmic decision-making and require transparency for public sector bodies when this is applied to decisions concerning individuals. The government is still carefully considering the report’s findings and recommendations and will respond in full this summer.
The Commission on Race and Ethnic Disparities published its findings on 31 March 2021 and its report is available on GOV.UK. The Employment and Enterprise chapter of the report includes the Commission’s research about Artificial Intelligence systems and bias in technology.
The Commission has recommended that Government issue guidance that clarifies how to apply the Equality Act to algorithmic decision-making and require transparency for public sector bodies when such is applied to decision making concerning individuals. The Government is now considering the Commission’s recommendations in detail and will respond in full this summer.
The Attorney General’s Office does not hold a central list of all information sharing gateways available to it.
Each information gateway will have its own management and governance requirements and will have to comply with the Data Protection Legislation.
The Attorney General’s Office (‘AGO’) takes the security of its data very seriously. All electronic gateways are managed and monitored through Government Legal Department (GLD) and Crown Prosecution Service HR, Finance, IT and the Unduly Lenient Sentence (‘ULS’) casework shared service provision. Where issues are identified, appropriate actions are taken. Revealing details of AGO monitoring capabilities in public would likely prejudice the capability, effectiveness and ability to strongly preserve those systems. In order to safeguard processing systems, we are unable to provide the information requested.
The Cabinet Office attaches great importance to the effective and timely handling of correspondence from MPs and Peers. On 26 May 2022, we published data on the timeliness of government responses to correspondence from MPs and Peers for 2021 on GOV.UK: https://www.gov.uk/government/publications/data-on-responses-to-correspondence-from-mps-and-peers-2021. Cabinet Office timeliness improved each quarter of 2021, with 89% of correspondence received from hon. Members in quarter four responded to within 20 working days.
As per the Guide to Handling Correspondence, updated by the Cabinet Office in July 2021, the target response time set by Departments for correspondence must not exceed 20 working days. The Cabinet Office continues to keep its own processes under review to further improve the time taken to respond.
I refer the Hon. Member to the Official Report, 6 July 2022, col. 11MC.
The source was the Dealroom Tech Health Check which is available at https://dealroom.co/blog/uk-tech-health-check-london-tech-week-2022.
This Government has been creating the right tax environment to promote investment and innovation. That is why we introduced the 130% super-deduction for capital investment and increased the Annual Investment Allowance from £200,000 to £1 million. We also have specific tax reliefs aimed at encouraging Venture Capital and early-stage investment, such as the Enterprise Investment Scheme and the Seed Enterprise Investment Scheme.
I refer the Hon. Member to the Official Report, 6 July 2022, col. 11MC.
The source was the Dealroom Tech Health Check which is available at https://dealroom.co/blog/uk-tech-health-check-london-tech-week-2022.
This Government has been creating the right tax environment to promote investment and innovation. That is why we introduced the 130% super-deduction for capital investment and increased the Annual Investment Allowance from £200,000 to £1 million. We also have specific tax reliefs aimed at encouraging Venture Capital and early-stage investment, such as the Enterprise Investment Scheme and the Seed Enterprise Investment Scheme.
The Prime Minister has told Secretaries of State and Permanent Secretaries to work together on producing a plan for returning the Civil Service workforce numbers to 2016 levels over the next three years. This work will be overseen by the Efficiency and Value for Money Cabinet Committee.
Places for Growth is contributing towards the Declaration on Government Reform and the Levelling Up priority by increasing the geographic spread of Civil Servants across the UK, increasing opportunities for people from a wider range of places, including establishing the Darlington Economic Campus where more than 110 HM Treasury staff are now in post. As the Levelling Up White Paper set out, departments have committed to moving more than 15,000 Civil Service roles out of Greater London by 2025, and 22,000 by 2030.
Secretaries of State will lead the drive for reductions within their departments and the Civil Service organisations for which they have responsibility. Planning is underway, with departments considering opportunities and the potential impacts that need to be mitigated. As plans are still in development, no decisions have yet been made.
It is the responsibility of every government department, including the Cabinet Office, to make a risk-based assessment of their use of cloud providers for the storage of government data up to “OFFICIAL” level, including UK citizens’ data. When considering a commercial provider, departments should take into account the cloud security principles developed by the National Cyber Security Centre (https://www.ncsc.gov.uk/guidance/implementing-cloud-security-principles).
The Cabinet Office carries out this risk assessment for each service it delivers to ensure that appropriate controls are in place to protect citizen data.
Departments are required to follow the Technology Code of Practice when choosing a cloud provider, and this is assessed as part of the spend controls function. Departments must show that they have chosen the technology which provides the best value for money while meeting user needs. The Central Digital & Data Office carries out ongoing engagement with departments to review their decision-making about hosting. This includes qualitative analysis through user research as well as spend controls.
Individual departments are responsible for their own commercial decisions, including the award of contracts.
In 2020, we launched a new model to deliver social value through Government's commercial activities. Central government organisations should use this model to take account of the additional social benefits that can be achieved in the delivery of its contracts, using policy outcomes aligned with this Government’s priorities.
Each Buying Authority has their own commercial spend controls that apply to their contracts with suppliers. Value-for-money and cost implications will vary on a case-by-case basis and it is down to each department to determine what these are in their respective circumstances. The Technology Code of Practice ensures that departments have multiple options available with a range of suppliers.
The driving principle behind public procurement policy is to award contracts on the basis of value for money. That means the optimum combination of cost and quality over the lifetime of the project, not just price alone. The best way to test for and to demonstrate this principle is via an open competition, as is required in most cases by public procurement legislation.
The government wants UK businesses to be successful in bidding for UK public contracts. That is why this government is committed to the procurement reform bill which will provide simpler, less bureaucratic processes for our businesses and better commercial outcomes for our public bodies - all while continuing to comply with our international commitments.
Through our new approach to extend the use of the Social Value Act, effective from 1 January 2021, additional social benefits can be taken into account in the delivery of contracts in a streamlined and standardised way, using policy outcomes aligned to this government’s priorities. From creating jobs and skills, building diverse supply chains and working towards Net Zero, embedding social value in procurement can help us to invest in our communities.
In addition to training commercial staff and making detailed guidance available to all on gov.uk, Cabinet Office and DCMS are working with supplier representative bodies and other external stakeholders to continue to build awareness.
There are a range of suppliers that compete to offer services via a number of framework agreements through the Crown Commercial Service, such as G-Cloud and Cloud Compute. Pricing and commercial offers in this industry are very competitive between suppliers.
Government does not place a cap on the proportion of cloud services provided by any of the current suppliers. Government Departments conduct their own assessments around value for money and implement their outsourcing strategies accordingly to meet their needs.
Details of Government contracts above £10,000 are published on Contracts Finder: https://www.contractsfinder.service.gov.uk/Search.
Publicly available spend data provided by the Crown Commercial Service reports that spend associated with these contracts totals at £371m through G-Cloud Framework Agreements since its 7th iteration up until the present time.
Details of Government contracts above £10,000 are published on Contracts Finder: https://www.contractsfinder.service.gov.uk/Search.
Publicly available spend data provided by the Crown Commercial Service reports that spend associated with these contracts totals at £371m through G-Cloud Framework Agreements since its 7th iteration up until the present time.
It is government policy not to comment on or discuss details of national security contracts.
These are commercial matters for the parties concerned. The Government was not involved at any point in the takeover talks on the sale of Newcastle United.
The role of the Electoral Commission is to ensure that elections and referendums are run effectively and in accordance with the law, to register political parties, and to regulate donations and loans to political parties and other campaigners and their spending. The Commission has recently launched a public awareness campaign about online political advertising.
The Government is committed to introducing a digital imprints regime. It will inform voters about the source of digital campaign material. The Electoral Commission will play a central role in ensuring compliance with the regime. This will be a big step forward in making UK politics more transparent and will empower voters to make informed decisions.
Tackling disinformation in all its forms remains a key priority for the Government. As set out in the Full Government Response, the Online Safety Bill will introduce a duty of care requiring companies to address harms on their online platforms, such as misinformation and disinformation. The new laws will have robust and proportionate measures to deal with misinformation and disinformation that could cause significant physical or psychological harm to an individual. Ofcom will be the independent online harms regulator and the Bill will give Ofcom the tools it needs to understand how effectively disinformation is being addressed so that it can take action as required.
This £10million fund will help deliver charitable projects and initiatives across the UK that support veterans with mental health needs. The Armed Forces Covenant Fund Trust, in addition to disbursing their regular funding of £10million per annum, will design and run an open grant competition to award the additional funding to organisations delivering in-scope programmes in support of veterans' mental health.
The £475,000 is new funding representing an opportunity to improve the ability of charities to work together and with government, enhancing the provision of support for veterans and the broader Armed Forces Community. Therefore the additional funds have been allocated to the Office for Veterans’ Affairs, within the Cabinet Office.
The Government committed funding at last year’s Spending Review to develop the first stage of an ambitious cross-government single sign-on and digital identity solution. Our vision is for members of the public to be able to access any online central government service simply, safely and securely using a single sign-on.
The Government is committed to working with its suppliers to tackle modern slavery in supply chains, as part of wider government action to tackle business compliance with the Modern Slavery Act.
The Modern Slavery Assessment Tool (MSAT) helps public sector organisations work in partnership with suppliers to improve the policies, processes and systems they have in place to identify and tackle the risk of modern slavery in supply chains. The MSAT records a broad range of information including risk assessments, due diligence and any training the supplier has undertaken to mitigate modern slavery risks. The government continues to work with its Strategic Suppliers in areas the MSAT has identified can be improved.
AWS’s publicly available ‘Amazon Supply Chain Standards’ policy sets out commitment to both labour and human rights.
The Government is committed to working with its suppliers to tackle modern slavery in supply chains, as part of wider government action to tackle business compliance with the Modern Slavery Act.
The Modern Slavery Assessment Tool (MSAT) helps public sector organisations work in partnership with suppliers to improve the policies, processes and systems they have in place to identify and tackle the risk of modern slavery in supply chains. The MSAT records a broad range of information including risk assessments, due diligence and any training the supplier has undertaken to mitigate modern slavery risks. The government continues to work with its Strategic Suppliers in areas the MSAT has identified can be improved.
AWS’s publicly available ‘Amazon Supply Chain Standards’ policy sets out commitment to both labour and human rights.
The Government is committed to working with its suppliers to tackle modern slavery in supply chains, as part of wider government action to tackle business compliance with the Modern Slavery Act.
The Modern Slavery Assessment Tool (MSAT) helps public sector organisations work in partnership with suppliers to improve the policies, processes and systems they have in place to identify and tackle the risk of modern slavery in supply chains. The MSAT records a broad range of information including risk assessments, due diligence and any training the supplier has undertaken to mitigate modern slavery risks. The government continues to work with its Strategic Suppliers in areas the MSAT has identified can be improved.
AWS’s publicly available ‘Amazon Supply Chain Standards’ policy sets out commitment to both labour and human rights.
Amazon Web Services (AWS) is a strategic supplier to the Government. As a strategic supplier, AWS is asked to complete the Modern Slavery Assessment Tool annually.
The information requested falls under the remit of the UK Statistics Authority. I have therefore asked the Authority to respond.
Tom Read was appointed as CEO of Government Digital Service following an external recruitment overseen by the Civil Service Commission. The selection panel included the Civil Service Chief Operating Officer, the Director General for Digital and Media Policy, Jacqueline De Rojas, and a Civil Service Commissioner.
Joanna Davinson was transferred within the Civil Service, and Paul Willmott was a direct appointment to an advisory role.
The information requested falls under the remit of the UK Statistics Authority. I have therefore asked the Authority to respond.
The Cabinet Office seeks to ensure that government organisations choose the right technology to meet their diverse hosting and cloud technology needs. Departments are required to follow the Technology Code of Practice when choosing a cloud provider. Public sector organisations can use the Digital Marketplace frameworks to purchase cloud services, hosting technology and support from a wide range of suppliers including many small and medium enterprises.
Data on government spending with suppliers is available on the Crown Commercial Service website. Departments also publish spend data on GOV.UK and are responsible for their own hosting decisions.
As part of the One Government Cloud Strategy, the government has already agreed a number of Memorandums of Understanding with suppliers including UKCloud, Microsoft, IBM, Google and AWS.
The Government is assessing the need for any actions arising from the Schrems II decision. Further announcements will be made in the usual way.
Data on government spending with suppliers is available on the Crown Commercial Service website. Departments also publish spend data on GOV.UK and are responsible for their own hosting decisions.
As part of the One Government Cloud Strategy, the government has already agreed a number of Memorandums of Understanding with suppliers including UKCloud, Microsoft, IBM, Google and AWS.
The Government is assessing the need for any actions arising from the Schrems II decision. Further announcements will be made in the usual way.
Data on government spending with suppliers is available on the Crown Commercial Service website. Departments also publish spend data on GOV.UK and are responsible for their own hosting decisions.
As part of the One Government Cloud Strategy, the government has already agreed a number of Memorandums of Understanding with suppliers including UKCloud, Microsoft, IBM, Google and AWS.
The Government is assessing the need for any actions arising from the Schrems II decision. Further announcements will be made in the usual way.
The Cabinet Office reviews the diversity of supply of government hosting and cloud services.
Departments are required to follow the Technology Code of Practice when choosing a cloud provider. Departments must show that they have chosen the technology which provides the best value for money while meeting user needs.
Details of spend with cloud hosting providers is available on the G-Cloud dashboard.
The Government published the updated Border Operating Model on 8 October. The document outlines the processes and systems required to move goods between GB and the EU from 1 January onwards, as well as the changes due in April and July of 2021 respectively.
As has been the case under successive administrations, the Civil Service Code and the Civil Service Management Code sets out relevant conduct standards.
The Counter Disinformation Unit was established on 5 March 2020, bringing together cross-Government monitoring and analysis capabilities. Its primary function is to provide a comprehensive picture of the extent, scope and the reach of disinformation and misinformation on Covid-19, and to work with partners to ensure appropriate action is taken.
Government has been identifying and resolving up to 70 incidents a week, often false narratives containing multiple misleading claims coordinating with departments across Whitehall to deploy an appropriate response. This can include a direct rebuttal on social media, working with platforms to remove harmful content, and ensuring public health campaigns are promoted through reliable sources. A range of criteria from engagement rates to speed of response is used to evaluate the effectiveness of the actions taken.
In August 2020 the Cabinet Office launched a recruitment campaign for a Government Chief Digital Officer, whose role will be to ensure we can realise the government’s ambition to make UK Government digital services the best in the world. Throughout this time the Government Digital Data and Technology function and Government Digital Service have continued to deliver critical services and expert advice.
The Government’s Data Ethics Framework and ‘Guide to Using AI in the Public Sector’, alongside other guidance are available on GOV.UK, to support ethical and safe use of algorithms in the public sector. Building on existing work on algorithmic and data ethics, the Government is now seeking to deliver more transparency on the use of algorithmic-assisted decision making within the public sector; and is working with leading organisations in the field of data and AI ethics on a proposed approach to algorithmic transparency.
The Government’s Data Ethics Framework and ‘Guide to Using AI in the Public Sector’, alongside other guidance are available on GOV.UK, to support ethical and safe use of algorithms in the public sector. Building on existing work on algorithmic and data ethics, the Government is now seeking to deliver more transparency on the use of algorithmic-assisted decision making within the public sector; and is working with leading organisations in the field of data and AI ethics on a proposed approach to algorithmic transparency.
Government Digital Service (GDS) leads the Government’s Digital, Data and Technology (DDaT) function. The GDS Academy provides training.
Regarding cyber skills, I refer the Hon. member to the answer given to PQs 53531 and 52225 on 09 June 2020. Details of funding are published in the Cabinet Office annual reports.
As the Government has previously stated, it is difficult for a single model or scenario to capture the varying impacts that will be felt across different parts of the economy. We want to stimulate and capture the widest possible range of analysis from economists and academics to businesses and civil society groups. As such, the Government intends to invite contributions in due course about the economic implications of the future relationship.
I refer the Hon. member to the answer given to PQ 59762 on 23 June 2020.
The economic impacts of our trade deal with the EU are already the subject of a thriving public debate.
A Written Ministerial Statement (HCWS271) made by the Chancellor of the Duchy of Lancaster on 8 June updated on the progress of negotiations.
We will continue to keep Parliament informed with appropriate analysis at appropriate times.
I refer the Hon. Member to the answer given to PQ 33512 on 21 April 2020.
The information requested falls under the remit of the UK Statistics Authority. I have therefore asked the Authority to respond.
National and local governments are using messaging to mobile phones as part of its COVID-19 communications campaign to ensure people across the UK continue to adhere to the guidance to 'stay at home, protect the NHS, and save lives.' This has included the Government sending a message to all mobile phone users to highlight the new rules in force. Local health providers, such as GP surgeries, are also using mobile messaging to advise people of revised ways to access health care services.
This Government has invested £1.68m in communications initiatives to counter disinformation since March 2018. These initiatives include the RESIST toolkit which helps public organisations respond to disinformation campaigns, and the 'Don’t Feed the Beast' behaviour change campaign to educate and empower those who see, inadvertently share and are affected by false and misleading information.
The Government regularly monitors the performance and financial health of all our strategic suppliers, including those in the IT sector which include DXC Technology.
We remain in regular discussions with DXC’s leadership team on the execution of their new strategy and continue to monitor their performance on Government contracts.
DXC appointed a new CEO in September 2019 who has launched a new strategy.
Quantum computing; 5G technologies and artificial intelligence are all areas which offer significant economic opportunities to the UK, as well as risks to our national cyber security that need to be managed.
Our development of Quantum Computing is funded by combined public and private investment through the UK’s ten year National Quantum Technologies Programme (NQTP).
Our current National Cyber Security Strategy (2016-2021) is delivering transformational change, building new capabilities and intervening to address the cyber threat. It is supported by £1.9bn investment designed to transform our resilience and continue to build our position as an innovative and expert world leader in cyber security.
The government's Sector Deal for AI launched in April 2018 and outlined a package of support for the sector.
This Government is committed to being open in their dealings with the press and to the principles of media freedom.
Ministers from across Government have appeared on and been interviewed by a wide range of media on a daily basis and have spent time speaking directly to the British public in other ways.
This Government is committed to being open in their dealings with the press and to the principles of media freedom.
Ministers from across Government have appeared on and been interviewed by a wide range of media on a daily basis and have spent time speaking directly to the British public in other ways.
There are no changes to the commercial agreements of levels of service with UK Government digital identity providers as a result of the UK leaving the EU.
The Government’s response to the digital identity consultation (Call for Evidence) will be published in due course.
Verify is delivered with private sector providers and next steps will be announced in the usual manner.
An extensive response to the PAC report was published in October 2019 and can be found at CP 176 – Treasury Minutes Government response to the Committee of Public Accounts.
There are no changes to the commercial agreements of levels of service with UK Government digital identity providers as a result of the UK leaving the EU.
The Government’s response to the digital identity consultation (Call for Evidence) will be published in due course.
Verify is delivered with private sector providers and next steps will be announced in the usual manner.
An extensive response to the PAC report was published in October 2019 and can be found at CP 176 – Treasury Minutes Government response to the Committee of Public Accounts.
There are no changes to the commercial agreements of levels of service with UK Government digital identity providers as a result of the UK leaving the EU.
The Government’s response to the digital identity consultation (Call for Evidence) will be published in due course.
Verify is delivered with private sector providers and next steps will be announced in the usual manner.
An extensive response to the PAC report was published in October 2019 and can be found at CP 176 – Treasury Minutes Government response to the Committee of Public Accounts.
There are no changes to the commercial agreements of levels of service with UK Government digital identity providers as a result of the UK leaving the EU.
The Government’s response to the digital identity consultation (Call for Evidence) will be published in due course.
Verify is delivered with private sector providers and next steps will be announced in the usual manner.
An extensive response to the PAC report was published in October 2019 and can be found at CP 176 – Treasury Minutes Government response to the Committee of Public Accounts.
There are no changes to the commercial agreements of levels of service with UK Government digital identity providers as a result of the UK leaving the EU.
The Government’s response to the digital identity consultation (Call for Evidence) will be published in due course.
Verify is delivered with private sector providers and next steps will be announced in the usual manner.
An extensive response to the PAC report was published in October 2019 and can be found at CP 176 – Treasury Minutes Government response to the Committee of Public Accounts.
Details of Ministers’ meetings with external organisations are published quarterly on GOV.UK.
I refer the Hon. member to the answer which I gave to PQ 1802 on 29 January 2020.
There are no local elections scheduled to take place in Northern Ireland in 2020.
The Scottish Parliament is responsible for the franchise for local elections in Scotland and elections to the Scottish Parliament.
Data collected by Innovate UK includes self-declared enterprise size. Their focus for measuring success is through formal evaluation of their programmes which will include data at a company level. Innovate UK are in the process of embedding their impact management framework which will collect data from the organisation supported to provide throughout the project lifecycle enabling them to understand the impact journey of those they support.
Innovate UK support plays a key role in bringing together different sectors to solve challenges through innovative technology use. Their thematic programmes do focus on certain challenges but rarely specify the technology and often cross sectors.
The Government has committed significant funds to support knowledge exchange between universities and the wider economy and society. Through its constituent research councils and Innovate UK, UK Research Innovation (UKRI) provided £166 million in 2021/22 to support knowledge exchange and commercialisation activity.
In addition to this, Research England’s Higher Education Innovation Funding and Research England Development Fund allocated £277 million to support knowledge exchange in universities in England in the same year. Research England manages the Connecting Capabilities Fund which has allocated £125 million.
The higher grant figure for projects starting in 2020 compared to 2021 was a combination of two large programmes (Strength in Places, and the Cell and Gene Therapy Catapult Manufacturing Innovation Centre) and Innovate UK’s part in responding to the Covid-19 pandemic which saw them launch three major programmes to help the UK business innovation ecosystem navigate the shock of the global pandemic.
The appointment of Ministers is a matter for my Rt hon Friend the Prime Minister.
I refer the hon. Member to the answer I gave the hon. Member for Hornsey and Wood Green on 6 July 2022 to Question 28901.
I refer the hon. Member to the answer I gave the hon. Member for Hornsey and Wood Green on 6 July 2022 to Question 28901.
‘Electronics, Photonics and Quantum’ was one of seven technology families defined by the Government in the Innovation Strategy (HMG 2021), which highlighted UK strengths in high potential emerging technologies.
The UK is a global leader in photonics, which contributed £14.5 billion to the UK economy in 2020. Government is keen to see this contribution grow across many applications, including manufacturing and agriculture. Agriculture was specifically cited in the Innovation Strategy as a domain for the convergence of the technology families.
Photonics was also included within the National Security Investment Act (NSI) to ensure its growth and adoption is secure.
The information requested is as follows:
Year | Total Award by Innovate UK | Award to Academic Institutions | Academic Institutions % of total |
2017 | £1,045m | £159m | 15% |
2018 | £2,353m | £179m | 8% |
2019 | £1,097m | £207m | 19% |
2020 | £1,491m | £243m | 16% |
2021 | £815m | £125m | 15% |
Innovate UK’s business awarded grant support by Sector based on their Company House registered Standard Industrial Classification (SIC) code (where available):
SIC 2007 Section Description | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
Accommodation and Food Service |
|
| £0.34m | £0.86m | £0.06m |
|
Administrative and Support Service | £19.09m | £17.30m | £57.93m | £39.52m | £23.77m | £3.78m |
Agriculture, Forestry and Fishing | £4.10m | £4.10m | £39.1m | £8.28m | £2.88m | £1.46m |
Arts, Entertainment and Recreation | £0.12m | £0.44m | £1.65m | £2.29m | £1.38m | £0.15m |
Construction | £2.62m | £4.49m | £7.68m | £8.09m | £1.61m | £0.36m |
Education | £0.33m | £3.18m | £2.12m | £5.81m | £0.70m | £0.79m |
Electricity, Gas etc. | £2.75m | £2.37m | £20.06m | £6.50m | £4.26m | £0.57m |
Financial and Insurance | £1.93m | £0.98m | £4.86m | £9.45m | £6.42m | £0.09m |
Human Health and Social Work | £1.96m | £7.04m | £9.27m | £9.97m | £3.75m | £2.56m |
Information and Communication | £69.90m | £73.02m | £89.01m | £172.27m | £99.32m | £25.08m |
Manufacturing | £313.78m | £318.42m | £221.84m | £361.92m | £241.56m | £32.31m |
Mining and Quarrying | £0.40m | £1.14m | £0.85m | £2.64m | £2.80m | £0.04m |
Other Service | £12.22m | £3.63m | £4.29m | £7.03m | £6.90m | £1.76m |
Professional, Scientific and Technical | £167.26m | £190.60m | £229.29m | £261.64m | £180.19m | £49.85m |
Public Administration | £0.14m | £0.07m | £1.79m | £1.93m | £0.08m |
|
Real Estate | £0.11m | £0.33m | £0.44m | £2.84m | £0.54m |
|
Transportation and Storage | £4.79m | £1.02m | £2.35m | £7.00m | £2.09m | £0.30m |
Water & Sewage | £3.16m | £3.84m | £1.56m | £5.80m | £5.34m | £1.68m |
Wholesale & Retail | £9.01m | £7.53m | £18.44m | £16.36m | £9.52m | £2.94m |
Unknown / Not Provided | £24.15m | £19.08m | £43.43m | £7.09m | £23.39m | £4.46m |
Data is not routinely collected on business funding stage. or technology preparedness level. Innovate UK programmes may have a focus for both of these scales but will support a range of innovation within them. Innovate UK’s role is to enable business-led innovation across the UK, helping businesses at all stages grow through technology development and commercialisation
This is a commercial matter. The Government does not have a legal mandate to intervene in private contracts between suppliers and a business customer.
My rt. hon. Friend the Secretary of State welcomes the recent progress to expand the range and speed of routes for international talent to come and work in the UK. Should the UK be unable to associate to Horizon Europe, continued mobility for researchers will be a top priority.
The UK’s preference remains to associate to Horizon Europe and we are disappointed that the EU continues to delay this. To provide reassurance, the Government has stepped in to ensure UK-based researchers who have obtained European Research Council grants will not lose out on funding.
Through the UK’s Horizon guarantee, the Government will fund eligible successful UK applicants who expect to sign grant agreements by December 2022 and who have been unable to sign agreements with the EU. This means that UK-based researchers can receive the full value of their funding to take their projects forward at their UK institutions.
In leading his independent Review of the Research, Development and Innovation Organisational Landscape, Sir Paul Nurse has undertaken a detailed evidence gathering process, including gathering input from hundreds of organisations in the UK’s RDI landscape. Work is underway to consider and finalise the Review’s recommendations, which will be presented to my rt. hon. Friend the Secretary of State for Business, Energy and Industrial Strategy prior to publication.
The Government has launched its consultation ‘Choice on units of measurement: markings and sales’. The consultation seeks further views on the potential impact of any changes to the law and an impact assessment will be carried out in due course.
The Government is reviewing the current law on units of measurement and has recently launched its consultation, ‘Choice on units of measurement: markings and sales’.
BEIS has not discussed this with UK Research and Innovation (UKRI) but continues to gather views through this early-stage consultation.
The most common form of converting methane into hydrogen is through steam or thermal reformation. Plasma technology could also be used to convert methane into hydrogen, but this has not yet been proven at commercial scale. This was not one of the hydrogen production routes modelled to support the development of the UK Low Carbon Hydrogen Standard as this was not considered to be amongst the main potential routes for production in the UK pipeline and lacked broadly available emissions data. As set out in the standard, the Government welcomes evidence from stakeholders on emerging technologies and potential production routes that could contribute to the UK’s future net zero energy system.
UK petrol and diesel prices since 2014 have been primarily driven by the underlying price in the global market of crude oil. These are also influenced by exchange rates and a range of other supply and demand factors specific to the wholesale markets for the fuels, including stock levels, logistics and distribution costs and seasonal demand variations.
BEIS publishes weekly national average pump prices online at https://www.gov.uk/government/statistics/weekly-road-fuel-prices.
BEIS does not publish wholesale prices nor UK exchange rates.
Projects need to be managed against the plan that has been provided, but the project management methodology is up to the applicant, based on what best meets the needs of the innovation.
In 2014 nominal fuel prices in the UK averaged 127.4 pence/litre (petrol) and 133.5 pence/litre (diesel), compared to average June 2022 prices (to 13/06/22) of 179.0 (petrol) and 187.9 (diesel). The changes in retail prices largely reflect those in traded wholesale prices for the fuels and exchange rates.
The nameplate atmospheric distillation capacity of all UK refineries decreased from 74.6 million tonnes/year at the end of 2013 to 62.3 million tonnes/year in March 2021.
The Government has asked the Competition and Markets Authority to conduct an urgent review of the fuel market, to explore whether the retail fuel market has adversely affected consumer interests.
Improving our ability to commercialise ideas from our world-leading research base is critical to becoming an Innovation Nation. That is why we committed in the Innovation Strategy to enhance the broad system of support for commercialisation, and why we provide financial support to a significant proportion of high-tech spinouts. This includes UKRI funding to de-risk specific R&D projects, and British Business Bank support for investors providing external capital. In the hon. Member’s own constituency, the Northern Accelerator, a partnership of five universities supported by £8.5 million from UKRI, is de-risking spinouts by establishing a seed investment fund.
The Government provided additional funding to Growth Hubs over the last two years to support businesses through EU Exit Transition and the COVID-19 Pandemic. The funding settlement for 2022/23 represents a return to a level closer to that of previous years.
The core offer of Growth Hub functions and services has the flexibility for Local Enterprise Partnerships (LEPs) to choose how they deliver services, including any enhancements according to local business needs.
BEIS does not hold data regarding completion of PhD courses for different student characteristics.
The Government wants NHS patients to benefit from innovative and effective new medicines and accelerated access through clinical research medicine via trials is a major pillar of the Life Sciences Vision. Responsibility for clinical trials sits with DHSC/NIHR but the National Institute for Health and Care Excellence (NICE) has recommended several ATMP that are now routinely funded for NHS patients. Recent initiatives such as the Innovative Licensing and Access Pathway (ILAP) and the Innovative Medicines Fund will further support the rapid introduction of effective new medicines, including ATMP, for the benefit of NHS patients.
Innovate UK and Medical Research Council, as part of UKRI have funded clinical trials in the UK for Advanced Therapy Medicinal Products (ATMP). Data is collected on an annual basis and information for 2022 is not yet available. From January 2021 – December 2021 there were 31 new ATMP clinical trial starts in the UK.
The National Quantum Technologies Programme, which is set to see £1 billion of public and private funding through its 10 year lifetime (2014-2024), is a collaboration between government, industry, and academia to drive the development of transformative research, products, and services in quantum. As part of this, UK Research and Innovation’s £173 million Commercialising Quantum Technologies Challenge (part of the Industrial Strategy Challenge Fund) includes dedicated funding for projects to remove the obstacles to scale up and to support manufacturing and system or service development. UK academia and industry have been further supported by bodies such as the Compound Semiconductor Catapult and the National Physical Laboratory’s Quantum Metrology Institute to test and validate quantum technologies. In order to build on these existing initiatives, the UK Government is developing a national strategy to be published later this year.
The R&D People and Culture Strategy recognises precarity facing researchers in early-career stages and sets out the actions that government and the R&D sector will take, working together, to address this.
BEIS has established a R&D People and Culture Ministerial Coordination Group to drive the successful implementation of the Strategy. One initial area of focus is supporting dynamic and sustainable career paths, which will look at the actions the sector can take individually and collectively to address early-career precarity alongside the government-led actions set out in the Strategy.
The most recent campaign for an Executive Chair for ESRC is the only campaign on records where no candidate was deemed suitable.
Appointment campaigns are confidential, so it is not possible to disclose details of applicants or the views of the panel.
BEIS and its partner organisations take data protection very seriously. UK Research and Innovation (UKRI) have issued a public statement on recent Researchfish activity.
BEIS and UKRI continue to work together to ensure systems and processes reinforce compliance with GDPR and that appropriate data protection guidance and training is available for all staff.
The bids were assessed by the Vaccine Manufacturing and Innovation Centre (VMIC Ltd) and VMIC Ltd and its Boards of Directors decided which bids to progress. The criteria used by VMIC Ltd to assess bids is commercially confidential information.
The Department for Business, Energy and Industrial Strategy, through the VTF, and UKRI-Innovate UK worked together closely up to and during the sale of the VMIC facility to ensure Government objectives were met.
Questions regarding VMIC’s Ltd’s non-government sources of funding should be directed towards VMIC Ltd.
The bids were assessed by the Vaccine Manufacturing and Innovation Centre (VMIC Ltd) and VMIC Ltd and its Boards of Directors decided which bids to progress. The criteria used by VMIC Ltd to assess bids is commercially confidential information.
The Department for Business, Energy and Industrial Strategy, through the VTF, and UKRI-Innovate UK worked together closely up to and during the sale of the VMIC facility to ensure Government objectives were met.
Questions regarding VMIC’s Ltd’s non-government sources of funding should be directed towards VMIC Ltd.
The bids were assessed by the Vaccine Manufacturing and Innovation Centre (VMIC Ltd) and VMIC Ltd and its Boards of Directors decided which bids to progress. The criteria used by VMIC Ltd to assess bids is commercially confidential information.
The Department for Business, Energy and Industrial Strategy, through the VTF, and UKRI-Innovate UK worked together closely up to and during the sale of the VMIC facility to ensure Government objectives were met.
Questions regarding VMIC’s Ltd’s non-government sources of funding should be directed towards VMIC Ltd.
The Government remains committed to and has taken unprecedented steps to support association to Horizon Europe. This includes detailing our financial commitments in the Spending Review and, as an exceptional step, setting out a guarantee to eligible, successful UK applicants to Horizon Europe, covering calls where grant agreements are signed by December 2022.This will ensure that important individual and collaborative projects can go ahead as planned.
Funding for the guarantee is demand-driven and will depend on the success rates of UK applicants to the Horizon Europe programme, as well as the duration of time the guarantee is operational.
The Government has always been clear that our priority is to support the UK’s research and development sector during this period of uncertainty. The guarantee extension announced on March 15, ensures that UK researchers can continue their work and that important international collaborations can continue. This second wave covers all eligible successful applicants to Horizon Europe, covering calls where grant agreements are expected to be signed by December 2022.Details regarding the scope and terms of the guarantee are available on the UKRI (UK Research & Innovation) website.
The guarantee delivered by UKRI allows awardees to receive the full value of their funding, subject to the terms of the guarantee. Detailed guidance on how to access the guarantee funding, and how payments are made, is available on the UKRI website.
The UK stands ready to formalise our association to EU programmes at the earliest opportunity. However, the EU’s delays to the UK’s association are putting long term science collaboration at risk.
We are urging the Commission to finalise the UK’s participation in Horizon as soon as possible. My rt. hon. Friend the Secretary of State and I have raised the ongoing delays with our counterparts in Europe, including Germany, France, Italy, Ireland, the Netherlands, Portugal and Sweden. The UK also discussed association and the delays at the EU-UK Specialised Committee in December 2021.
Supporting the UK’s research and development sector through this period of uncertainty remains our top priority. In order to provide reassurance, the UK Government has guaranteed funding for the first and second waves of eligible successful applicants to Horizon Europe. And if the UK is unable to associate to Horizon Europe we will be ready to introduce a comprehensive alternative programme of international science, research and innovation collaborations.
The Government’s position remains to associate to Horizon, at the earliest opportunity. However persistent delays from the EU are causing uncertainty for the UK’s R&D sector. Supporting the UK’s research and development sector through this period of uncertainty is our top priority. If the UK is unable to associate to Horizon Europe soon and in time to make full use of the opportunities it offers, the Government will introduce a comprehensive alternative programme of international science, research and innovation collaboration, building on those outlined in the R&D Roadmap.
Funding for UK entities, successful in the latest Euratom Research & Training research call, is covered by the existing UKRI guarantee. This ensures UK entities can sign agreements and collaborative nuclear fission projects can go ahead. Relevant Euratom stakeholders have been contacted regarding the availability of the guarantee. £4m of funding has been agreed to provide this guarantee. It remains our policy to associate to Euratom R&T. Contracts for the next wave of Euratom R&T are unlikely to be signed before late 2023 and relevant teams across government will continue to work towards ensuring UK entities have the confidence to apply for the second wave of grants.
Innovate UK didn’t have the right to appoint board members to VMIC Ltd's Board of Directors. Innovate UK and the Vaccines Taskforce did attend VMIC Ltd's Board meetings as Observers.
Dr Peter Highnam has withdrawn from accepting the CEO role for personal reasons. Once the agency is operational, full remuneration details of ARIA’s senior leadership team will be published in the usual way and included in the agency’s annual reports and accounts.
The initial recruitment campaign returned a strong field of candidates and several were considered by Ministers. However, none were ultimately deemed suitable. Another campaign will start shortly with a view to attracting a wider range of candidates.
VMIC is a private company and due to commercial sensitivity, we cannot state how much funding we expect to recover from the grants provided to the Vaccine Manufacturing and Innovation Centre (VMIC).
The Government is supportive of VMIC Board’s decision to sell its Harwell facility and expects it to deliver strong positive value for money for the taxpayer. Catalent, the facility’s purchaser, is a global leader in the MRNA sector, with substantial experience manufacturing Moderna’s mRNA COVID vaccine, as well as the Pfizer, Janssen and AstraZeneca vaccines. Catalent is planning to invest up to £120m in the facility and provide up to 400 jobs. With this investment, Catalent will be able to complete and sustainable use the facility for the development and manufacture of biologic therapies and vaccines, potentially including mRNA: a valuable contribution to the UK’s vaccine resilience.
The Government has committed to support successful initial UK applicants to Horizon Europe, who are unable to sign grant agreements with the EU due to delays by the EU in formalising our association to the programme.
On 15 March we announced an extension of the guarantee to a second wave of eligible, successful applicants to ensure that important individual and collaborative projects can go ahead as planned. This will extend the guarantee to grant agreements expected to be signed by December 2022 and will enable awardees to receive the full value of their funding.
Supporting the UK’s research and development sector through this period of uncertainty is our top priority. The agreed funding provisions recognise that this support is demand-driven and determined by the number of successful UK applications. All eligible, successful UK applicants will be supported. As Horizon Europe only recently started, data on successful bids will be reviewed as the programme progresses, and as grants are issued via UKRI.
The Government is not selling the VMIC facility. VMIC UK Ltd is a private company and has always been a private company. The decision to sell was made by VMIC UK Ltd’s Board of Directors. UKRI-Innovate UK and the Vaccine Taskforce are communicating with VMIC to help ensure the UK has a strong onshore vaccine ecosystem.
Innovate UK has exercised its right to be an observer on the VMIC Board of Directors since the inception of VMIC. Innovate UK has been a board observer when the sale of the facility has been discussed.
The Vaccine Taskforce is in contact with VMIC UK Ltd’s Board of Directors following their decision to pursue a sale. Decisions regarding how best to pursue the company’s objectives are made by VMIC UK Ltd’s Board of Directors and executive team. The Government will continue to support the UK’s domestic vaccine manufacturing, vaccine innovation and health emergency response capability.
Details on any potential acquirers of VMIC UK Ltd or any potential return to Government are commercially sensitive.
The Government is not selling the VMIC facility. VMIC UK Ltd is a private company and has always been a private company. The decision to sell was made by VMIC UK Ltd’s Board of Directors. UKRI-Innovate UK and the Vaccine Taskforce are communicating with VMIC to help ensure the UK has a strong onshore vaccine ecosystem.
Innovate UK has exercised its right to be an observer on the VMIC Board of Directors since the inception of VMIC. Innovate UK has been a board observer when the sale of the facility has been discussed.
The Vaccine Taskforce is in contact with VMIC UK Ltd’s Board of Directors following their decision to pursue a sale. Decisions regarding how best to pursue the company’s objectives are made by VMIC UK Ltd’s Board of Directors and executive team. The Government will continue to support the UK’s domestic vaccine manufacturing, vaccine innovation and health emergency response capability.
Details on any potential acquirers of VMIC UK Ltd or any potential return to Government are commercially sensitive.
The Government is not selling the VMIC facility. VMIC UK Ltd is a private company and has always been a private company. The decision to sell was made by VMIC UK Ltd’s Board of Directors. UKRI-Innovate UK and the Vaccine Taskforce are communicating with VMIC to help ensure the UK has a strong onshore vaccine ecosystem.
Innovate UK has exercised its right to be an observer on the VMIC Board of Directors since the inception of VMIC. Innovate UK has been a board observer when the sale of the facility has been discussed.
The Vaccine Taskforce is in contact with VMIC UK Ltd’s Board of Directors following their decision to pursue a sale. Decisions regarding how best to pursue the company’s objectives are made by VMIC UK Ltd’s Board of Directors and executive team. The Government will continue to support the UK’s domestic vaccine manufacturing, vaccine innovation and health emergency response capability.
Details on any potential acquirers of VMIC UK Ltd or any potential return to Government are commercially sensitive.
The Government is not selling the VMIC facility. VMIC UK Ltd is a private company and has always been a private company. The decision to sell was made by VMIC UK Ltd’s Board of Directors. UKRI-Innovate UK and the Vaccine Taskforce are communicating with VMIC to help ensure the UK has a strong onshore vaccine ecosystem.
Innovate UK has exercised its right to be an observer on the VMIC Board of Directors since the inception of VMIC. Innovate UK has been a board observer when the sale of the facility has been discussed.
The Vaccine Taskforce is in contact with VMIC UK Ltd’s Board of Directors following their decision to pursue a sale. Decisions regarding how best to pursue the company’s objectives are made by VMIC UK Ltd’s Board of Directors and executive team. The Government will continue to support the UK’s domestic vaccine manufacturing, vaccine innovation and health emergency response capability.
Details on any potential acquirers of VMIC UK Ltd or any potential return to Government are commercially sensitive.
The Government is not selling the VMIC facility. VMIC UK Ltd is a private company and has always been a private company. The decision to sell was made by VMIC UK Ltd’s Board of Directors. UKRI-Innovate UK and the Vaccine Taskforce are communicating with VMIC to help ensure the UK has a strong onshore vaccine ecosystem.
Innovate UK has exercised its right to be an observer on the VMIC Board of Directors since the inception of VMIC. Innovate UK has been a board observer when the sale of the facility has been discussed.
The Vaccine Taskforce is in contact with VMIC UK Ltd’s Board of Directors following their decision to pursue a sale. Decisions regarding how best to pursue the company’s objectives are made by VMIC UK Ltd’s Board of Directors and executive team. The Government will continue to support the UK’s domestic vaccine manufacturing, vaccine innovation and health emergency response capability.
Details on any potential acquirers of VMIC UK Ltd or any potential return to Government are commercially sensitive.
We recognise the important role that the private non-profit sector, such as charities, play in both funding and performing R&D. In 2019, the private non-profit sector funded £1,766 million worth of R&D and performed £843 million of R&D. The Greater South East contributes the highest share of private non-profit expenditure on R&D, with 84% of total expenditure in 2019 vs 16% for outside of the region.
The Levelling Up White Paper shows that we are committed to increasing total investment in R&D across the whole of the UK, of which private non-profit R&D is an important element.
In setting the R&D mission, BEIS referred to published research on leverage, which found that we expect public R&D to leverage at least £2 of private R&D funding for every £1 of public R&D expenditure over the long term. This is based on a 2020 study published by BEIS and conducted by Oxford Economics, which estimates that each £1 of public R&D investment eventually stimulates between £1.96 and £2.34 of private R&D investment, the study found that almost all leverage is realised within 15 years.
BEIS is working with DLUHC and other government departments on measuring and reporting on missions in the Levelling Up White Paper and further detail will be made available in due course.
Innovate UK is not a voting member of the VMIC UK Ltd Board of Directors. It holds observer status on the Board.
£5,009m has been allocated to successful Medicines and Diagnostics Manufacturing Transformation Fund (MDMTF) projects to date. These allocations have no impact on the Life Sciences Innovative Manufacturing Fund resource. Applicants from the one-year MDMTF can also apply to the successor fund if the application is for a different project.
Discussions on alternative launch providers and the roll out of OneWeb satellites are a matter for OneWeb. These commercially sensitive discussions are likely to take time given the fast-changing situation and complexity of launch planning. We will engage with OneWeb in its thinking on alternative launch providers where appropriate.
In the Autumn Budget, my Rt. Hon. Friend Mr Chancellor of the Exchequer announced £354 million for UK life sciences manufacturing. This includes funding to further enhance the UK’s health emergency responsiveness and capability in vaccine production. Areas of focus for this funding will include mRNA capability following the success of mRNA COVID-19 vaccines, and investments which will strengthen the resilience of the UK’s vaccine supply chains. The Vaccine Taskforce has undertaken considerable market engagement across the global vaccine sector to maximise impact for the UK taxpayers.
The £60 million Life Sciences Innovative Manufacturing Fund (LSIMF) was announced on 2 March 2022. The launch was accompanied by a UK wide engagement of life sciences manufacturing companies, Trade Associations and other key sector stakeholders.
The objective of the Life Sciences Innovative Manufacturing Fund (LSIMF) is to incentivise capital investments in manufacturing across the UK. Applicants will be encouraged to describe R&D aspects of their manufacturing proposal as part of the Fund’s economic assessment. 75% of life sciences manufacturing jobs are located outside of London and England’s South-East and we expect the LSIMF to create highly-skilled jobs across all regions of the UK.
The fund seeks to leverage £300 million of gross private sector manufacturing investment by March 2025, more than four times the public investment of £60 million. Applicants will undergo an economic assessment to ensure that their proposal provides a sufficient level of private sector investment. Applications will also be assessed on their alignment with the fund’s objectives of boosting health resilience, deploying innovation and minimising environmental impact.
As Horizon Europe only recently started, data on successful bids will be reviewed as the programme progresses. The regional distribution of funding under Horizon 2020 – the predecessor programme to Horizon Europe – is publicly available data. It can be seen in the table below. UK entities are already eligible to apply to Horizon Europe calls ahead of formal UK association to the programme.
UK Regions | % of UK receipts |
London | 25.3% |
South East | 17.0% |
Scotland | 11.4% |
East of England | 11.3% |
South West | 7.9% |
Yorkshire and Humber | 6.3% |
North West | 6.1% |
West Midlands | 5.4% |
East Midlands | 3.1% |
North East | 2.9% |
Wales | 2.0% |
Northern Ireland | 1.0% |
OneWeb’s launch contract is with Arianespace, a French company. As a non-majority shareholder in OneWeb (17.6%), we cannot comment on arrangements between Arianespace and its suppliers.
Giving the “105” number a similar status as the 999/112 Public Emergency Call Service number would require a change to primary legislation - most likely to the Communications Act (2003) - which would require thorough consultation with Industry, Ofcom, and the Department for Digital, Culture, Media and Sport.
The UK stands ready to formalise our association to EU programmes, but disappointingly there have been persistent delays from the EU. We cannot wait forever for association to be finalised, and so we are preparing for all scenarios going forward. We will support the UK R&D sector through this uncertain period, either by association to Horizon or through the implementation of an alternative UK programme, if this proves necessary.
We are currently developing a bold and ambitious long-term UK offer that combines the benefits of Horizon association whilst also strengthening the UK’s global position and enhancing our unique selling points as a global science superpower.
It will build on the Integrated Review and R&D Roadmap and include a strong and attractive offer to encourage talented individuals to build their careers here, developing the skills and workforce the UK needs as well as investing in those areas of research and innovation which support tomorrow's economy, including technologies and missions as set out in the Innovation Strategy.
The Department primarily funds research into energy generation through UK Research and Innovation (UKRI), which in 2020-2021 funded £205 million towards alternative energy resources.
The figures for 2021-22 will be available in the autumn.
As I noted on 27 February, BEIS is rapidly reviewing all Russian beneficiaries of UK science, research, technology and innovation funding. This is a fast moving policy area and the Government will provide an update in due course.
Innovation Accelerators are a new pilot approach to supporting three UK city regions to become major, globally competitive centres for research and innovation. They will be locally led partnerships involving leaders in local government, business and R&D institutions, working with national Government and R&D funders.
The partnerships will develop plans to accelerate innovation-led growth in their city regions, building on local strengths and opportunities. They will receive dedicated support from the UK Government and will have access to a new £100m fund to support transformational R&D projects that grow R&D strengths, attract private investment, boost innovation diffusion, and maximise the combined economic impact of R&D institutions.
Catapults may be a part of Innovation Accelerators but are sector specific, designed to support innovation and de-risk the transition from research to commercial delivery for small, medium and large businesses. They achieve this through the provision of R&D infrastructure, specialist knowledge and expertise, partnership and collaboration building capabilities and business support.
The UK stands ready to formalise our association to EU programmes at the earliest opportunity, but disappointingly there have been persistent delays from the EU.
In order to provide reassurance, the Government has already committed to support the first wave of successful UK applicants to Horizon Europe who are unable to sign grant agreements with the EU due to these delays.
This guarantee, delivered by UK Research and Innovation (UKRI), will enable awardees to receive the full value of their funding.
The Government will monitor the situation closely and is keeping all measures, including the guarantee, under constant review.
We encourage the UK sector to continue applying to Horizon Europe calls and to continue forming consortia.
Further information on how to apply and technical guidance is on the UKRI website.
In this financial year almost 95% of the UK Atomic Energy Authority’s £216m budget was for fusion projects and programmes. This includes fusion enabling technologies such as robotics, as well as the infrastructure and facilities.
The remainder was allocated to the Shareholder Programme Agreement, which pays for historical legal commitments relating to the UK Atomic Energy Authority’s predecessor bodies, or improving accessibility to apprenticeships.
The Levelling Up White Paper announced that there will be a structured process of visits, at ministerial level, across the whole of the UK in the months following publication of this White Paper, to discuss how levelling up can be successfully achieved in that area and to gather feedback. I look forward to meeting with regional leaders in England and across the UK as part of this process.
In the Levelling Up White paper BEIS committed to work to collect data at a regional level for all of its R&D spend.
UKRI publish detailed breakdowns of their funding data at a regional level annually, the latest available data is on UKRI's website at https://www.ukri.org/our-work/what-we-have-funded/regional-distribution-of-funding/. In addition, the UKRI Gateway https://gtr.ukri.org/
provides data on publicly funded research and innovation which is searchable by year and region.
The Vaccine Taskforce and UK Research and Innovation are engaged with the Vaccine Manufacturing and Innovation Centre (VMIC), which is a private company, as well as with other companies, to ensure the UK has a strong domestic vaccine manufacturing capability to contribute to the UK’s resilience against COVID-19 and other future health emergencies. Details of the sale process are commercially sensitive.
The Government has invested over £380 million to date in the UK’s onshore vaccine manufacturing capacity and capability. At the recent Autumn Budget, and as part of the ‘living with COVID-19’ plan, my Rt. Hon. Friend Mr Chancellor of the Exchequer announced a further £354 million for UK life sciences. This includes funding to strengthen UK vaccine manufacturing resilience for the COVID-19 response, including COVID-19 variants, and potential future health emergencies, among other projects.
In the Life Sciences Vision, the Government committed to a healthcare mission to improve translational capabilities in neurodegeneration and dementia. The Office for Life Sciences are working with the Medical Research Council, industry, charities, academia and the wider sector to scope this Mission.
The Government has committed to invest £375 million in neurodegenerative disease research over the next five years to fund projects into a range of diseases including dementia. We are working on ways to significantly boost further research on dementia to support the delivery of the moonshot and we will be setting out our plans on dementia for England for future years in 2022. This will include our ambitions for dementia research and boosting dementia research funding.
I refer the Hon. Member to the answerI gave her on 8 February 2022 to Question 116927.
We are investing £200 million over the next three years in 12 Strength in Places projects to develop R&D capacity and support local growth across the UK. The Department is currently working to set detailed R&D budgets through to 2024/25. Further details about how the funding is allocated across the Spending Review period will be announced in due course.
The Advanced Propulsion Centre will invest almost £16 Million in a consortium developing electric propulsion systems for heavy goods vehicles in Cwmbran, Wales and Edinburgh, Scotland through the EPIC project. The EPIC project is listed as one of the three projects totalling £54 Million joint investment from APC and industry. Further details of the projects can be found at the following link:
The EPIC Project is scheduled to last 42 months with the grant being paid over that period to the consortium members in arrears on the basis of work carried out.
The Advanced Propulsion Centre will invest almost £16 Million in a consortium developing electric propulsion systems for heavy goods vehicles in Cwmbran, Wales and Edinburgh, Scotland through the EPIC project. The EPIC project is listed as one of the three projects totalling £54 Million joint investment from APC and industry. Further details of the projects can be found at the following link:
The EPIC Project is scheduled to last 42 months with the grant being paid over that period to the consortium members in arrears on the basis of work carried out.
The Levelling Up White Paper set out the Government’s mission to increase domestic public investment in R&D outside the Greater South East by at least one third over the Spending Review period and at least 40 percent by 2030.
In support of this, BEIS will make levelling up one of the objectives of its R&D investment strategy and will aim for the regions outside the Greater South East to receive at least 55% of its R&D budget by 2024/25.
The Department is currently working to set detailed R&D budgets through to 2024/25. Further details about how the funding is allocated across the Spending Review period will be announced in due course.
The recently published Heat and Buildings Strategy acknowledges the potential of geothermal energy and sets out the Government’s commitment to continue to monitor developments in geothermal heat in the UK and assess whether the technology provides a cost-effective option for the future.
Officials are therefore currently reaching out to industry involved in the deep geothermal sector to improve the Government’s understanding of the barriers for investment and the potential of a geothermal heat pipeline. The Government will use this information to identify the next steps that can be taken both by government and industry to realise the potential of the sector for decarbonising heat.
The Regulator Ofgem monitors households' experiences with the energy market, including those with prepayment meters, through their Consumer Engagement Surveys. The most recent survey, published in April 2021, suggested that 21% of prepayment meter households had temporarily been disconnected from their supply because their meter had run out of credit. This report is available online at: https://www.ofgem.gov.uk/sites/default/files/docs/2021/04/consumer_survey_2020_update_on_engagement.pdf.
The Price Cap continues to ensure that 22 million households, including the 4 million who use a pre-payment meter, pay a fair price for their energy.
In addition, Ofgem’s new licence conditions rules protect Prepayment Meter customers at risk of self-disconnection and include requirements on suppliers to offer emergency and friendly-hours credit to all these customers and to offer additional support credit to customers in vulnerable circumstances.
The recently published Heat and Buildings Strategy acknowledges the potential of geothermal energy and sets out the Government’s commitment to continue to monitor developments in geothermal heat in the UK and assess whether the technology provides a cost-effective option for the future.
Officials are therefore currently reaching out to industry involved in the deep geothermal sector to improve the Government’s understanding of the barriers for investment and the potential of a geothermal heat pipeline. The Government will use this information to identify the next steps that can be taken both by government and industry to realise the potential of the sector for decarbonising heat.
The UK Government will ask the Office for National Statistics (ONS) and the UK Government Office for Science to work with all Whitehall departments to collect and publish sub-national data on R&D spending. The timescales for this programme of work will be agreed collectively with all the parties in due course. We work with the ONS and the UK Government Office for Science to determine the most appropriate means of publishing the data.
The Levelling Up White Paper announced that the Science Minister would convene a biannual meeting with respective Ministers in Scotland, Wales and Northern Ireland. This biannual meeting will further support close working relationships between the UK, Scotland, Wales and Northern Ireland and ensure mutually beneficial outcomes.
Innovation Accelerators will be locally led partnerships involving leaders in local government, business and universities, working with national Government and R&D funders. They’re designed to pilot a new approach to supporting three places in the UK to become major, globally competitive centres for research and innovation.
Each partnership will develop plans to boost innovation and attract new R&D investment in their city regions, building on existing work that each of these three city regions have already done to identify local strengths and opportunities, including through Science and Innovation Audits and local innovation plans.
They will receive bespoke support from the UK Government, led by BEIS in partnership with other departments.
The IAs will be centred on the three city regions, but partnerships will have flexibility to expand the reach of their activity to surrounding areas if desired. The £100m of R&D funding for the Accelerators will be awarded through a process run by UKRI and will support high quality R&D projects to grow local innovation ecosystems in the three pilot areas.
This Government is fully committed to levelling up across the whole of the UK. The funding for the Oxford to Cambridge arc is one of ten grants we have provided across all parts of the UK to support space sector growth and connect the space sector ecosystem. The activity delivered by the Open University will reach into the South midlands and across to East Anglia and will ensure expertise in the region is accessible to the whole of the UK and vice versa.
In the Levelling Up White paper BEIS committed to work to collect this data at a regional level for all of its R&D spend.
UKRI publish detailed breakdowns of their funding data at a regional level annually, the latest available data is on UKRI's Regional distribution of funding – UKRI. In addition, the UKRI Gateway https://gtr.ukri.org/ provides data on publicly funded research and innovation which is searchable by year and region.
Our record increase in R&D investment to £20bn by 2024/25 means universities and businesses in the Greater South East will continue to benefit from public R&D investment. Public R&D funding will continue to be awarded competitively and open to universities, businesses and organisations across the whole UK.
The Paul Nurse review will look across the landscape of UK organisations undertaking all forms of research, development and innovation. This review will highlight the strengths to be nurtured and any comparative weaknesses to be tackled, and make recommendations for addressing them. Sir Paul Nurse will report on his review in early summer 2022.
The UK Space Agency has awarded a grant of £7.35m to Virgin Orbit to enable horizonal launch from Spaceport Cornwall. This is supported by Cornwall Council funding to support the establishment of Spaceport Cornwall, which should be operational in the next few months.
Further details of how this funding will be allocated will be announced in due course.
In 2021, the Government, via UK Research and Innovation, agreed to invest £172 million over five years for the new Hartree National Centre for Digital Innovation (HNCDI). This is met with a £38 million in-kind contribution from IBM.
We engaged widely in developing proposals to pilot Innovation Accelerators in three UK city-regions. This included learning from the R&D Place Advisory Group established in 2020, which included UK and international experts.
We expect to co-develop the pilot Innovation Accelerators in partnership with the three UK city-regions selected, and confirm the metrics used to assess their success as part of finalising the business plans for the pilots. Where appropriate, these will align with the mission on R&D published in the Levelling Up White Paper and the objectives of the Innovation Strategy
We will give decision-makers at all levels the information they need to grow thriving local innovation economies. Our new open data tool, co-developed by BEIS and NESTA, provides high quality and accessible evidence on sub-regional R&D systems in the UK.
The Levelling Up White Paper sets out a cross-Government commitment that domestic public investment in R&D outside the Greater South East will increase by at least 40% by 2030, and over the Spending Review period by at least one third.
We have not set specific targets for each region - the 40% increase refers to regions outside the Greater South East in aggregate. This ensures we are not constraining the ambitions of any one region.
This mission, which refers to R&D expenditure across all Government Departments, will complement more targeted interventions in places with high R&D potential, including the £100m investment Innovation Accelerators supporting three UK city regions to become major, globally competitive centres for research and innovation.
By 2030, domestic public investment in R&D outside the Greater South East will increase by at least 40%, and over the Spending Review period by at least one third.
We have not set specific targets for each region - the 40% increase refers to regions outside the Greater South East in aggregate. This ensures we are not constraining the ambitions of any one region.
This mission will complement more targeted interventions in places with high R&D potential, including the £100m investment Innovation Accelerators supporting three UK city regions to become major, globally competitive centres for research and innovation.
BEIS will aim for the regions and nations outside the Greater South East to receive at least 55% of its research and development (R&D) funding by 2024/25.
To support this BEIS will make levelling up one of the objectives of its R&D investment strategy to ensure its £39.8bn settlement between 2022/23–2024/25 boosts R&D and economic growth across the whole of the UK.
In some areas like Net Zero, BEIS expects at least £7 in every £10 it invests will be invested outside the Greater South East over the spending review period.
UKRI’s new objective will help to deepen its commitment to delivering social and economic impact for citizens across the whole UK. UKRI will set out how it intends to deliver on this objective in its strategy later in 2022.
One element of that response will be a suite of resources that teams across UKRI can use to incorporate levelling up into the design and delivery of their programmes, helping UKRI to work towards a more diverse and connected system across academia, businesses and the public sector.
The Spending Review committed to an increase in public R&D spending to £20bn by 2024-25, contributing to the economy-wide target to invest 2.4% of GDP in R&D by 2027.
The Levelling Up White Paper set the mission for domestic public investment in R&D outside the Greater South East to increase by at least one third over the Spending Review period and at least 40 percent by 2030, with that additional government funding seeking to leverage at least twice as much private sector investment over the long term to stimulate innovation and productivity growth. This is baselined against spending levels in 2021-22 and doesn’t include EU Programmes Association funding.
The UK Government has asked the Office for National Statistics (ONS) and the UK Government Office for Science to work with all Whitehall departments to collect and publish sub-national data on their R&D spending. This will allow us to track progress on the mission to 2030.
Government considered a range of evidence and analysis in developing the R&D measures in the Levelling Up White Paper, including Nesta’s ‘The Mission £4bn’ report.
The Levelling White Paper sets out a series of measures to ensure that R&D supports levelling up across the country. Public investment in R&D outside the Greater South East will increase by at least one third over the Spending Review period and at least 40 percent by 2030. This additional government funding will seek to leverage at least twice as much private sector investment over the long term to stimulate innovation and productivity growth.
Supporting delivery of this goal, BEIS will make levelling up one of the objectives of its R&D investment strategy and will aim for the regions outside the Greater South East to receive at least 55% of its R&D budget by 2024/25.
Alongside increasing investment in innovation across the country, BEIS will invest £100m between 2022-3 and 2024-5 to pilot three new Innovation Accelerators centred on Greater Manchester, the West Midlands and Glasgow City-Region. Innovation Accelerators will develop UK innovation clusters, boosting economic growth by investing in high-quality projects to grow R&D strengths, attract private investment, boost innovation diffusion, and maximise the combined economic impact of R&D institutions.
The Levelling Up White Paper sets out how we will maximise the contribution of innovation to levelling up by building on existing and emerging strengths across the country.
We are committed to taking a place-based approach – tailoring support to the research, development and innovation strengths of different places and developing policies in partnership with local government, businesses and R&D institutions.
New Innovation Accelerator pilots will support three places in the UK to become major, globally competitive centres for research and innovation. In addition to receiving bespoke support from the UK Government, a total of £100m R&D funding will be available to these places for projects between 2022/23 and 2024/25. Should these pilots prove successful, we will consider how to build on this approach in future.
The policies in the Levelling Up White Paper have been informed by views from across the UK - including our R&D Place Advisory Group, which includes Local Enterprise Partnership, and the Devolved Administrations - to understand how we can build on our excellence in research and innovation so that more people and places benefit.
The Department for Health & Social Care will invest £375 million in neurodegenerative disease research over the next five years to fund projects into a range of diseases including dementia.
Following the Spending Review, the Department for Business, Energy & Industrial Strategy is currently working to set detailed R&D budgets through to 2024/25. Further details of how this funding will be allocated will be announced in due course.
BEIS published “The relationship between public and private R&D funding” (BEIS Research Paper Number 2020/010) on 1 July 2020 at https://www.gov.uk/government/publications/research-and-development-relationship-between-public-and-private-funding(opens in a new tab) carried out by Oxford Economics Ltd
They estimated the monetary impact of the long-run leverage rate, suggesting that each £1 of public R&D eventually stimulates between £1.96 and £2.34 of private R&D
The study drew on OECD data for 41 countries from 1961 to 2017 with varying degrees of completeness.
The level of private investment generated varies by sector (including maturity), stage of research and type of R&D funding programme. It can therefore vary considerably across programmes.
For Innovate UK programmes, , Innovate UK has invested £4 billion of grant funding and generated £2.3 billion of direct matched funding from businesses, since 01/01/2012. On top of this, evaluations show net additional follow-on private investment of between £1-£5 within 1-4 years of receiving a grant.
Across Innovate UK’s core programmes, validated programme evaluations demonstrate a return to the economy of approximately of up to £7 for every £1, as well as spill-over impacts estimated to be 2 to 3 times larger.
Making the most of R&D in places around the UK is a key government priority. The 2021 Spending Review sees record levels of investment in the UK’s world-leading research base with public spending on Research & Development (R&D) increasing by £5 billion per annum to £20 billion in 2024-25. The substantial uplift to research and science funding will not only allow the UK to build on our core strengths but will also provide opportunities to grow research and innovation investment across the entire country. Further details of how this funding will be allocated will be announced in due course.
The Levelling Up White Paper sets out how we will maximise the contribution of innovation to levelling up. This includes a new mission that, by 2030, domestic public investment in R&D outside the Greater South East will increase by at least one third over the Spending Review period and at least 40 percent by 2030, with that additional government funding seeking to leverage at least twice as much private sector investment over the long term to stimulate innovation and productivity growth.
In support of this, BEIS has committed to invest at least 55% of its domestic R&D funding outside the Greater South East by 2024/25.
The Levelling Up White Paper sets out how we will maximise the contribution of innovation to levelling up by building on existing and emerging strengths across the country.
We are committed to taking a place-based approach – tailoring support to the research, development and innovation strengths of different places and developing policies in partnership with local government, businesses and R&D institutions.
New Innovation Accelerator pilots will support three places in the UK with world class research strengths to grow their local innovation clusters by attracting industrial R&D, creating new career opportunities and creating a more vibrant innovation ecosystem in the wider region. In addition to receiving bespoke support from the UK Government, a total of £100m R&D funding will be available to these places for projects between 2022/23 and 2024/25. Should these pilots prove successful, we will consider how to build on this approach in future.
The policies in the Levelling Up White Paper have been informed by views from across the UK - including our R&D Place Advisory Group, which includes Local Enterprise Partnership, and Mayoral Combined Authority bodies - to understand how we can build on our excellence in research and innovation so that more people and places benefit.
Business expenditure on R&D (BERD) demonstrates the amount of R&D performed by UK businesses, and is the nearest for private sector investment. In 2020, the regions of Greater London, the East of England, and South East of England accounted for 55% of total UK BERD. Since 2010, BERD outside these regions has ranged from 45% - 49%, peaking at 49% in 2016.
The Levelling Up White Paper sets out how we will maximise the contribution of innovation to levelling up. This includes a new goal that domestic public investment in R&D outside the Greater South East will increase by at least one third over the Spending Review period and at least 40 percent by 2030, with that additional government funding seeking to leverage at least twice as much private sector investment over the long term to stimulate innovation and productivity growth.
BEIS has published a R&D spatial data tool (https://www.gov.uk/guidance/access-research-and-development-spatial-data) which allows users to access, visualise and compare indicators that show the scale of R&D systems at a subregional level over time. This includes metrics that proxy for private R&D and innovation and can be reviewed for all UK regions.
We are implementing the Innovation Strategy, which sets out the Government’s vision to make the UK a global hub for innovation by 2035. It aims to boost private sector investment across the whole of the UK, which is critical to achieve our target of 2.4% of GDP being invested in R&D by 2027.
Through the Strategy, we have committed to take action in areas such as regulation and public procurement, creating the conditions for all businesses to innovate. However, this is just the starting point, and over the coming and months and years we will continue to build an enabling environment for private sector investment in R&D.
Following the Spending Review, we are also ensuring that government funding attracts private – including from overseas – investment. For example, we have increased funding for core Innovate UK programmes, reaching c.£1bn per year by 2024/25, which are highly successful in securing private sector leverage.
In September 2021, the Government convened a Life Sciences Scale-up Taskforce (the Taskforce), who were asked to consider how we can drive progress on the ease with which Life Science companies across the UK can start, grow, and scale up. This Taskforce was industry-led and not funded by Government.
In December 2021, the Taskforce provided its response to my Rt. Hon. Friend the Secretary of State for Business, Energy and Industrial Strategy. This included recommendations on issues that inhibit scale-up and growth, identified throughout the Life Sciences Vision (the Vision). These recommendations will now be considered by the Government as it takes forward implementation of the Vision.
The UK stands ready to formalise our association to Horizon Europe at the earliest opportunity. This remains our priority, but disappointingly there have been persistent delays from the EU.
The SME instrument has been replaced under Horizon Europe with the EIC Accelerator. UK companies are already eligible to apply for Accelerator calls ahead of formal association as set out in the EIC Accelerator Guide for Applicants. Under Horizon 2020, UK organisations won a total of nearly €190m from the SME Instrument, with 453 UK organisations participating in the SME instrument and a total of 492 UK participations in the SME instrument.
We have always been clear that our priority is to support the UK’s research and development sector and we will continue to do this in all future scenarios.
As announced at the Spending Review, in the event that the UK is unable to associate to Horizon Europe, the funding allocated will go to UK science, research and innovation programmes instead. I set out my priorities in such a scenario in an open letter in November, including my ambition for stronger SME engagement.
The Government is committed to developing a globally competitive Life Sciences investment ecosystem where private and public Life Sciences companies can access long-term capital within the UK from investors committed to building successful companies here in the UK.
To support this, in July 2021, Government launched the £200m Life Sciences Investment Programme. This will leverage around £400m of private sector investment, making around £600m financing available for the sector over the course of the next 10 years. In addition, the Government established an industry-led Life Sciences Scale-up Taskforce, which aims to drive progress on the ease with which Life Science companies can start, grow, and scale up in the UK.
I refer the Hon. Member to the answer I gave her on 14 January 2022 to Question 101715.
Analysis conducted by the Office for Life Sciences using data from S&P Capital IQ showed that in the first 10 months of 2021, UK Life Sciences companies raised a total of £6.6bn in equity finance. This is an increase of 1,000% since 2012 when the equivalent figure was £0.6bn. These figures include public and private investment and cover the sectors of Biotechnology, Pharmaceuticals, Life Sciences Tools and Services, Health Care Equipment and Supplies and Health Care Technology. They were set out in the press release accompanying the recent Biopharmaceutical CEO Roundtable, held on 2 December 2021.
The 2020 Biosciences and Health Sector Statistics publication shows that net employment in the UK life sciences industry increased by 31,500 between 2011 and 2020, and that during that period, net employment increased in England, Scotland, Wales and Northern Ireland.
Annex: Supporting Data
Region | Net change in employment between 2011 and 2020 |
London | 8,200 |
East of England | 4,900 |
South East | 4,500 |
Yorkshire and the Humber | 4,000 |
North West | 2,500 |
Northern Ireland | 2,200 |
Wales | 1,700 |
North East | 1,700 |
South West | 1,500 |
East Midlands | 800 |
Scotland | 400 |
West Midlands | -800 |
Total | 31,500 |
Source: Office for Life Sciences: Bioscience and Health Technology Statistics 2020
Figures for the National Institute for Health Research (NHIR) and the Medical Research Council (MRC) will be available in the coming months.
Government spend on dementia research 2020-21 | |
Economic and Social Research Council (ESRC) | £8,025,232.10 |
Biotechnology and Biological Sciences Research Council (BBBSRC) | £1,500,000 |
Engineering and Physical Sciences Research Council (EPSRC) | £11,477,620 |
Please note that BBSRC provided an estimated figure for dementia research based on their broad portfolio of underpinning relevance (£29m in 2020/21).
We estimate that between 30% to 55% of plastics consumed in the UK are produced in the UK. This range depends on whether plastic imports to the UK are consumed domestically or are re-exported, however the Department does not hold this exact data.
The billions we are investing in R&D, skills and support for digital technology adoption through initiatives like Made Smarter and Help to Grow is providing a competitive business environment for British manufacturers. It is attracting new investment, developing new export opportunities, and securing new high-value jobs in our industrial heartlands.
UK Research and Innovation (UKRI) funds a variety of projects related to plastics including projects improving sustainability and recyclability of plastics in the UK. For example, the Smart Sustainable Plastic Packaging Challenge, with £60m of funding from UKRI through the Industrial Strategy Challenge Fund and matched by £149m from industry, is supporting academic-led research to address known problems and to support industry-led collaborative research and development of new technologies, de-risking innovative plastics sustainability projects, and delivering over 230kt per annum of additional recycling capacity. The output of this capacity is intended to be used back in packaging and will make a real contribution to the gap of recycled plastics in the UK.
The introduction of Extended Producer Responsibility (EPR) for Packaging will see businesses that place packaging on the market bear responsibility for the costs of managing that packaging once it becomes waste. It will incentivise businesses to design and use packaging that is easier to recycle, and to increase the recycling of packaging waste.
Finally, The UK Plastic Packaging Tax will be introduced from 1 April 2022 to encourage the use of recycled plastic in packaging, and in turn stimulate increased levels of recycling and collection of plastic waste, diverting it away from landfill or incineration. It is estimated that this will lead to an increase in the use of recycled plastic by 40% in 2022-23.
The billions we are investing in R&D, skills and support for digital technology adoption through initiatives like Made Smarter and Help to Grow is providing a competitive business environment for British manufacturers. It is attracting new investment, developing new export opportunities, and securing new high-value jobs in our industrial heartlands.
UK Research and Innovation (UKRI) funds a variety of projects related to plastics including projects improving sustainability and recyclability of plastics in the UK. For example, the Smart Sustainable Plastic Packaging Challenge, with £60m of funding from UKRI through the Industrial Strategy Challenge Fund and matched by £149m from industry, is supporting academic-led research to address known problems and to support industry-led collaborative research and development of new technologies, de-risking innovative plastics sustainability projects, and delivering over 230kt per annum of additional recycling capacity. The output of this capacity is intended to be used back in packaging and will make a real contribution to the gap of recycled plastics in the UK.
The introduction of Extended Producer Responsibility (EPR) for Packaging will see businesses that place packaging on the market bear responsibility for the costs of managing that packaging once it becomes waste. It will incentivise businesses to design and use packaging that is easier to recycle, and to increase the recycling of packaging waste.
Finally, The UK Plastic Packaging Tax will be introduced from 1 April 2022 to encourage the use of recycled plastic in packaging, and in turn stimulate increased levels of recycling and collection of plastic waste, diverting it away from landfill or incineration. It is estimated that this will lead to an increase in the use of recycled plastic by 40% in 2022-23.
The Department for Business, Energy and Industrial Strategy is in the early phases of developing the Inter-Ministerial Group, to support ongoing discussions on research and development. Further details about the group will be formalised and made available in due course.
In order to support the Government’s ambitions to cement the UK’s status as a global science superpower and an innovation nation, the Department for Business, Energy and Industrial Strategy is in the early phases of developing an Inter-Ministerial Group, to support ongoing cross-Government discussions on research and development. Further details about the group will be formalised in due course.
Science and research allocations for 2010/2011 were published in The Allocation of Science and Research Funding 2011/12 to 2014/15. Allocations for 2021 were published in May 2021 in BEIS research and development budget allocations 2021 to 2022.
The Vaccine Manufacturing Innovation Centre (VMIC) UK is a private company, limited by guarantee, and as such the UK Government does not exercise any ownership rights.
VMIC has been granted £206m of Government funding to date to support the delivery of the facility, including grants since the beginning of the COVID-19 pandemic to increase vaccine manufacturing capacity. Reflecting the public funding VMIC has received, UK Research and Innovation (who have been managing the grant on behalf of the Vaccine Taskforce) will be required to ‘consent’ to any sale of the company or its assets and have confirmed that they will work closely with the Vaccine Taskforce in performing this function.
The Vaccine Manufacturing Innovation Centre (VMIC) UK is a private company, limited by guarantee, and as such the UK Government does not exercise any ownership rights.
VMIC has been granted £206m of Government funding to date to support the delivery of the facility, including grants since the beginning of the COVID-19 pandemic to increase vaccine manufacturing capacity. Reflecting the public funding VMIC has received, UK Research and Innovation (who have been managing the grant on behalf of the Vaccine Taskforce) will be required to ‘consent’ to any sale of the company or its assets and have confirmed that they will work closely with the Vaccine Taskforce in performing this function.
The Government reaffirmed its commitment to supporting equity finance across the UK at the 2021 Spending Review. We announced over £1.6 billion of new funding for the British Business Bank’s (BBB) regional investment funds, which provide debt and equity finance for SMEs to help them with their next stage of growth.
This funding will allow the BBB to set up new funds in Scotland and Wales and build on its existing activity in Northern Ireland. It will also see existing regional funds expand to allow businesses in the North East and South West of England to benefit from debt and equity finance provision.
We have also committed an additional £150 million to the Regional Angels Programme, which helps entrepreneurs across the UK access early-stage equity finance. Of the initial £100m commitment through this programme, 80 per cent went to businesses outside London and the South East of England.
The Global Britain Investment Fund will provide £354m to UK Life Sciences. The funding will be spent over a three-year period from April 2022. HM Treasury aggregates funds from various funding streams to finance the investments announced at Spending Review 2021, including the Global Britain Investment Fund. The individual funding sources for the Global Britain Investment Fund are therefore not known.
Research England Quality-related Research funding is allocated largely on the basis of the volume of highest quality research as assessed by REF2014. Through the “Expanding Excellence in England” programme, Research England is seeking to grow excellent research capacity where excellence exists but is currently at a small scale with potential for growth.
UKRI are publishing detailed breakdowns of their funding data at a regional level annually to increase transparency of how places benefit from R&D funding. The latest available data is at: https://www.ukri.org/our-work/what-we-have-funded/regional-distribution-of-funding/2018-to-2019-regional-distribution-of-funding/#contents-list.
The Office for Artificial Intelligence is a joint unit between BEIS and DCMS, reporting to directors in both BEIS and DCMS and accountable to Secretaries of State in both departments.
The recently published AI Strategy confirmed the Government’s commitment to continue to support the development and deployment of these technologies. The Strategy included commitments to launch a National AI Research and Innovation Programme to improve coordination and collaboration between the country’s researchers and a programme aimed at continuing to develop AI in sectors based outside of London and the South East.
The budget for the Office for Artificial Intelligence and the scale of funding provided to these programmes will be set through departmental business planning processes, which are ongoing.
The Autumn 2021 Spending Review announced record-breaking investment in the UK’s world leading research base, increasing by £5.2 billion to £20 billion per annum by 2024/25 in line with the target of UK economy-wide R&D investment reaching 2.4% of GDP by 2027.
The £1.4 billion Global Britain Investment Fund (GBIF) will drive investment in industries of national strength, including automotive, which has key regional clusters in the West Midlands, North West and North East.
The Autumn Budget and Spending Review 2021 represents a record investment in UK R&D – providing £20 billion per annum by 2024-25. This will support a wide range of initiatives to cement the UK as a global science and technology superpower. Following the Spending Review, BEIS is currently working to set detailed R&D budgets to 2024/25. Further details of how this funding will be allocated will be announced in due course.
The Vaccine Manufacture and Innovation Centre (VMIC) is a private company, limited by guarantee without share capital, and as such the UK Government does not exercise any ownership rights. Questions regarding VMIC’S ownership shares should be directed to VMIC.
The UK stands ready to formalise our participation in Horizon Europe and other Union programmes, but disappointingly there have been persistent delays from the EU. Our participation in these programmes should be a “win-win” for everyone and further delays will benefit neither the UK nor EU.
Most recently, this issue was discussed at a meeting of the joint Specialised Committee on Participation in Union Programmes on Tuesday 21st December 2021.
It was important that this Specialised Committee meet to discuss the major outstanding issue of UK association and the treatment of UK participants in the meantime. We were pleased to meet but are disappointed that delays persist, and the Commission has still not provided clarity on when this will be resolved. We will continue to press on this.
We have always been clear that our priority is to support the UK’s research and development sector and we will continue to do this in all future scenarios.
Government spending on dementia
£m | 2018-19 | 2019-2020 |
National Institute for Health Research (NIHR) | £31.6 | £29 |
Medical Research Council (MRC) | £45.2. | £42.1 |
Economic and Social Research Council (ESRC) | £6.1 | £4.6 |
Biotechnology and Biological Sciences Research Council (BBBSRC) on neuroscience | £30 | £29 |
Total | £112.9 | £104.7 |
Figures for the current financial year 2021/22 not yet available.
The Government remains open to all initiatives that will have a demonstrable positive impact on vaccine production and distribution. We do not intend to waive intellectual property rights as we believe this would have precisely the opposite effect.
Our robust international intellectual property framework protects the ability of the world’s leading scientists to come up with new ideas and innovations. This has been critical in underpinning innovators’ confidence to form over 300 vaccine manufacturing partnerships. It will allow us to continue to develop vaccines and treatments at unprecedented pace and meet our ultimate goal of saving lives, throughout the pandemic. There is no evidence that waiving intellectual property rights would help us to meet this goal. Waiving intellectual property rights would dismantle the very framework that helped to produce COVID-19 vaccines at the pace and scale now seen.
While we must continue to ensure vaccine production needs are met globally, the WHO news release of 7 October made it clear that: “With global vaccine production now at nearly 1.5 billion doses per month, there is sufficient vaccine from a supply perspective to achieve global vaccination targets”. We must therefore also focus on issues of distribution and delivery, in order to successfully vaccinate the globe and ensure we are all safe.
The UK Shared Prosperity Fund (UKSPF) is a domestic successor to the EU Structural Fund programme, worth over £2.6 billion. The UKSPF will help people access opportunity in places in need, such as ex-industrial areas, deprived towns and rural and coastal communities, and for people in disadvantaged groups across the UK.
The Government values the insights of stakeholders from different sectors and areas across the UK, which supports the development and delivery of the fund. Since the publication of the UKSPF Heads of Terms at Spending Review 2020, Department for Levelling Up, Housing and Communities (DLUHC) officials have engaged widely on the UKSPF and DLUHC will continue to engage stakeholders as the fund is developed.
Furthermore, the Government’s Innovation Strategy, published in July, outlines our emerging thinking on how to ensure that research and innovation benefits the economy and society across the UK as part of Government’s objectives to level up the UK economy. The 2021 Spending Review sees record levels of investment in the UK’s world-leading research base. Government investment in research and development (R&D) will increase by £5 billion to £20 billion p.a. by 2024-25. This will not only allow the UK to build on our core strengths, but will also provide opportunities to grow research and innovation across the entire country.
The forthcoming Levelling Up White Paper will also play a critical role in setting out how R&D together with skills, infrastructure, business support and regeneration can improve living standards, grow the private sector, and increase and spread opportunity across the UK.
As the EU proposes new approaches, it will be important for the UK to respond appropriately, using our increased adaptability and freedoms as we capitalise on the opportunities of EU Exit. I look forward to scrutinising the EU’s proposal in due course.
The UK is incredibly well placed in this space, through well-established feedback mechanisms between regulated businesses, regulators and policy makers and broader work currently underway reviewing the existing regulatory framework and the important regard already paid to innovation friendly regulation in the UK Innovation Strategy’s commitments.
The UK stands ready to formalise our association to Horizon Europe at the earliest opportunity, but disappointingly there have been persistent delays from the EU.
UK participation in Horizon Europe benefits both the UK and the EU, bringing the expertise of UK researchers and innovators to vital collaborations, including those tackling global challenges such as climate change.
The regional distribution of funding under Horizon 2020 – the predecessor programme to Horizon Europe – can be seen in the table below, including for the North East and London. Horizon 2020 funding data is not available by individual cities (other than London). As Horizon Europe only recently started, data on successful bids will be reviewed as the programme progresses. UK entities are already eligible to apply ahead of formal association.
UK Regions | % of UK receipts | |
London | 25.3% | |
North East | 2.9% | |
|
|
Following the Spending Review, BEIS will set R&D budgets through to 2024/25. Further details of how this funding will be allocated will be announced in due course.
The Biotechnology and Biological Sciences Research Council, part of UK Research and Innovation (UKRI), funds a variety of doctoral training opportunities in partnership with others, details of these can be viewed on the UKRI website here: Studentships – UKRI.
The Department for Education have also asked the Office for Students to reform the Strategic Priorities Grant for 2021-22. These reforms included the reallocation of high-cost subject funding towards the provision of high-cost subjects that support the NHS and wider healthcare policy; science, engineering and technology subjects; and specific labour market needs. As a result, the total funding for high-cost subjects, such as medicine, engineering and other high-cost subjects, is 12% (£81m) higher in 21/22 compared to 20/21.
Details of Innovate UK grants are published on their website and can be viewed here:
The Government consulted on the 17 areas of the economy in which certain acquisitions will be subject to mandatory notification under the National Security and Investment Act 2021. These are specified in the National Security and Investment Act 2021 (Notifiable Acquisition) (Specification of Qualifying Entities) Regulations 2021. Vaccine manufacturing does not feature as an area in its own right but some of the activities involved in vaccine manufacturing are addressed.
Future Fund: Breakthrough has announced two investments to date, both in England. One of the companies is based in London and the other in Bristol. Details of the amounts invested are commercially confidential.
Officials are working closely with VMIC and other third parties to ensure that the UK retains a strong domestic vaccine manufacturing capability to contribute to our response to COVID-19 and resilience to other future health emergencies. We believe VMIC will play an important role in the UK’s vaccine ecosystem. At present, these discussions are commercially sensitive.
VMIC is a private company. Mergers and acquisitions of private companies are primarily commercial matters for the parties concerned and the Government does not comment on the details of individual transactions. We remain strongly committed to support UK leadership in vaccines.
As we announced in November, the Government will invest £375 million in neurodegenerative disease research over the next five years to fund projects into a range of diseases including dementia.
The tech sector benefits from a range of support measures, including research grants and loans from Innovate UK; networks and industry contacts accessed through Catapults; and the government’s new ‘Help to Grow’ schemes that will help smaller businesses across the UK learn new skills, reach new customers and boost profits.
Companies at all stages of growth, including those operating in the tech sector, can access the advice and support they need through the Business Support Helpline, the British Business Bank’s finance hub, and government services available through GOV.UK.
Government support for the tech sector is coordinated by the Digital Economy Council, working with private sector bodies including Tech Nation and Tech UK. Tech Nation supports tech entrepreneurs at every stage of the business lifecycle. Its growth-stage programme, Upscale, is now in its seventh year and is providing 60 hours of expert support and coaching, spread over six months, to a cohort of 30 founders and senior leadership teams.
The British Business Bank crowds-in private capital to the tech sector through its commercial subsidiary, British Patient Capital (BPC), and through regional funds in Cornwall and the Isles of Scilly, the Midlands and the North of England. In announcing its 2021 results, BPC noted that 26 of its 51 fund investments were in the ‘venture growth’ space, defined as funds that invest at Series B onwards.
In addition to its own investments, BPC also runs Future Fund: Breakthrough, a £375 million programme focused on growth-stage companies. The fund announced its first tech investment on 17 November 2021, in the £60 million Series D round of Bristol-based Ultraleap, a provider of machine-learning-based hand tracking software.
The Government has always been clear that our priority is to support the UK’s research and development sector and maintain strong international collaborations and we will continue to do this in all future scenarios.
As announced in the 2021 Spending Review, in the event that the UK’s association to Horizon Europe is not formalised by the EU, the funding allocated to Horizon association will go to UK government R&D programmes, including those to support international partnerships.
In November, the Government announced a guarantee to provide a financial safety net for successful UK applicants to Horizon Europe, while the government continues to push to formalise our association as soon as possible. At the same time, I published an open letter to the R&D sector setting out the UK’s commitment to association, but also our priorities for supporting the sector in a scenario where association proves not possible. These build on the UK Research and Development Roadmap, which sets out a solid foundation for our plans in different scenarios.
There has been a strong response to the Life Sciences Investment Programme request for proposals, which was published on 7 July 2021. The British Business Bank is holding talks with fund managers who expressed an interest, and the first investments are expected to be announced during the first half of 2022.
The 2021 Spending Review set out the Government’s plan to increase public R&D spending to £22 billion a year by 2026/27 and restates our target for UK economy-wide R&D investment to reach 2.4% of GDP by 2027. Private investment forms around 2/3rd of current activity, so it is only by working with innovative businesses and funders from the private sector that we will reach 2.4%. The Innovation Strategy commits to using levers such as procurement, better regulation and the identification of key technologies as a means to create the conditions for private sector investment in innovation across the country.
We want to encourage businesses to invest in local economies and communities. The Innovation Strategy also outlined our thinking on how to grow innovation clusters, and to ensure that research and innovation benefits the economy and society across the UK through both systemic and targeted measures that respond to the varying needs of places. It announced £127 million in new investment through the Strength In Places Fund. This fund has pioneered bringing together consortia of diverse local actors, including business, to develop the R&D capabilities of places across the UK to improve local economic growth. The Government is investing over £300 million in 12 major projects in nations and regions across the UK, attracting an additional £340 million of investment including from private firms.
The forthcoming Levelling Up White Paper will take a comprehensive place-based approach to economic growth and will set out more detail on how the Government will support levelling up through R&D.
In the development of the Innovation Strategy, the Department worked across Government, engaging at both Ministerial and official level and with over 400 businesses and organisations across the whole of the UK.
The Innovation Expert Group, which was announced as part of the R&D Roadmap in 2020, featured representatives from innovative UK businesses and business-focused trade bodies. It played a key role in supporting the development of the UK Innovation Strategy by facilitating conversations between officials from across Whitehall and a broad spectrum of UK businesses. The discussions generated continue to help us to refine government's innovation policy thinking.
Since the Innovation Strategy was published, the Department has continued a high level of engagement with businesses.
In addition, in early 2022 and as announced in the Innovation Strategy, we will establish the Business Innovation Forum with representatives from the UK's largest R&D intensive businesses, UK startups and scaleups, and experts in the funding and commercialisation of innovation. The forum will galvanise action from the business community and provide an opportunity for officials from UKRI and other public bodies to interact with key innovation stakeholders in addition to the interaction they already undertake with industry.
The Department will also continue to facilitate bilateral conversations with UK businesses on innovation policy this year.
A breakdown of expenditure for the whole of UKRI is set out in the UKRI annual report and accounts for 2020-21 (Note 2 Page 158)[1].
A breakdown of expenditure for the whole of UKRI is set out in the UKRI annual report and accounts for 2020-21 (Note 2 Page 158)[1].
The Government does not propose to invest further in OneWeb. Seventy percent of OneWeb’s workforce is UK-based. In addition, the active component of OneWeb’s current generation of satellites (the payload) is manufactured in the UK by Teledyne.
OneWeb is aware of the Government’s ambition for it to further expand UK content in its satellites, including onshoring the manufacturing of its second-generation satellites.
The Government’s strategy for vaccine manufacturing and innovation can be found in the Life Sciences Vision policy paper, published in July 2021.
Officials are working closely with the Vaccine Manufacturing Innovation Centre (VMIC) and other third parties to ensure that the UK retains a strong domestic vaccine manufacturing capability to contribute to our response to COVID-19 and resilience to other future health emergencies. At present, these discussions are commercially sensitive.
The National Security and Investment Act 2021, which comes into force fully on 4 January, gives the Secretary of State powers to intervene in acquisitions of control of certain entities and assets that have given rise to or may give rise to a risk to national security. In addition, the Enterprise Act 2002 was amended in 2020 to allow the Secretary of State to intervene in mergers and takeovers on the public interest grounds of maintaining in the United Kingdom the capability to combat, and to mitigate the effects of, public health emergencies.
The Government’s strategy for vaccine manufacturing and innovation can be found in the Life Sciences Vision policy paper, published in July 2021.
Officials are working closely with the Vaccine Manufacturing Innovation Centre (VMIC) and other third parties to ensure that the UK retains a strong domestic vaccine manufacturing capability to contribute to our response to COVID-19 and resilience to other future health emergencies. At present, these discussions are commercially sensitive.
The National Security and Investment Act 2021, which comes into force fully on 4 January, gives the Secretary of State powers to intervene in acquisitions of control of certain entities and assets that have given rise to or may give rise to a risk to national security. In addition, the Enterprise Act 2002 was amended in 2020 to allow the Secretary of State to intervene in mergers and takeovers on the public interest grounds of maintaining in the United Kingdom the capability to combat, and to mitigate the effects of, public health emergencies.
We have already secured the doses we need for everyone in the UK who requires a booster this Winter, but, like every responsible government, we continue to plan for all possible future scenarios. The UK is proactively managing our vaccine supply and we are in regular contact with the vaccine manufacturers.
The Government’s strategy for vaccine manufacturing and innovation can be found in the Life Sciences Vision policy paper, published in July 2021.
Officials are working closely with the Vaccine Manufacturing Innovation Centre (VMIC) and other third parties to ensure that the UK retains a strong domestic vaccine manufacturing capability to contribute to our response to COVID-19 and resilience to other future health emergencies. At present, these discussions are commercially sensitive.
The National Security and Investment Act 2021, which comes into force fully on 4 January, gives the Secretary of State powers to intervene in acquisitions of control of certain entities and assets that have given rise to or may give rise to a risk to national security. In addition, the Enterprise Act 2002 was amended in 2020 to allow the Secretary of State to intervene in mergers and takeovers on the public interest grounds of maintaining in the United Kingdom the capability to combat, and to mitigate the effects of, public health emergencies.
The Future Fund issued loans under a Convertible Loan Agreement (CLA) on standard terms. This is a public document, available on the British Business Bank’s website. Section 5(a) of the CLA sets out the criteria for conversion, which occurs automatically three years after the date of the CLA or earlier in the event of a sale of the company or a funding round. The CLA also defines the conditions associated with the equity shares, which depend on the event that triggered the conversion.
The latest available data from the British Business Bank (BBB) is available here: https://www.british-business-bank.co.uk/covid-19-emergency-loan-schemes-repayment-data/.
The latest available data from the British Business Bank (BBB) is available here: https://www.british-business-bank.co.uk/covid-19-emergency-loan-schemes-repayment-data/.
Analysis is underway, and no reliable conclusions can be drawn from the analysis so far.
Across the UK, 251,342 applications for a CBIL were made; 109,877 were successful. As of our final evaluation of July 2021, 87,809 Coronavirus Business Interruption loans (CBIL) have been offered in England, to the value of £23.03bn. 919 loans were offered to the companies in the North East of England to the value of £694,592,700.
As of our final evaluation of the scheme of July 6 2021, 1,357,116 Bounce Back Loans have been offered in England, to the value of £41.47bn. In the North East of England, 48,262 loans were offered to the value of £1,341,695,001.
Across the UK, 2,094,858 applications for a Bounce Back Loan were made; 1,560,309 were successful. We do not hold this data at regional level.
The Follow-On Interim Evaluation of the Pilot Innovation Loans Programme will be published shortly.
The pilot programme’s interim evaluation has focused on:
1. What is the interest in, and demand for, Innovation Loans?
2. What is the nature of the businesses applying, and the projects which form the focus of the applications for funding?
3. What would have happened to the innovation projects supported if they had not been offered these loans?
4. How effective are the processes of implementation and what are the experiences of the customer journey?
5. What evidence is there of progress towards the achievement of intended outputs, outcomes, and impacts?
Future Fund: Breakthrough is a £375 million, UK-wide programme that invests alongside private investors to increase the size of later-stage funding rounds. On 17 November 2021, British Patient Capital announced the first investment under this programme, as part of a £60 million Series D funding round for Bristol-based company Ultraleap. There is no upper limit for round size and hence future investments may be in rounds above the £100 million threshold identified by the Council for Science and Technology.
The Life Sciences Investment Programme is a £200 million government commitment, aiming to attract at least £600 million of investment in total to be deployed within 10-15 years. It is a targeted, sectoral intervention to address the sector-specific funding gap faced by growth-stage life sciences companies in the UK. The programme will invest in funds rather than individual companies, with the aim of enabling the emergence and development of specialist UK-based fund managers.
Both Future Fund: Breakthrough and the Life Sciences Investment Programme are administered by British Patient Capital, a commercial subsidiary of the government-owned British Business Bank.
In addition to these specific programmes, the Government is considering the analysis and recommendations made by the Council for Science and Technology and is engaging with institutional investors to explore the scope for an increased allocation of investment capital to research-intensive UK companies, particularly for scale-up investments over £100 million. This builds on the actions set out in the Government’s Innovation Strategy, published in July, to support access to scale-up finance for innovative science and technology companies.
All Innovate UK grants and loans are made public via (Innovate UK funded projects since 2004 – UKRI ). Transparency data also includes the location and region that the company is registered in.
Funding decisions by UK Research and Innovation are based on the quality of applications and value for money to the taxpayer.
A total of 1,190 Future Fund applications were successfully completed. The number of Convertible Loan Agreements (CLAs) issued in each region of the UK is provided in the table below. A total of 655 applications for the Future Fund were unsuccessful. A regional breakdown of these applications is not available as the information has not been verified.
The location of Future Fund applicants broadly reflects the distribution of equity investment across the UK. The British Business Bank addresses regional disparities in access to finance through its regional investment funds and the Regional Angels Programme, both of which were extended at the recent Spending Review.
Region | CLAs issued |
East Midlands | 21 |
East of England | 90 |
London | 649 |
North East | 30 |
Northern Ireland | 13 |
North West | 84 |
Scotland | 23 |
South East | 134 |
South West | 43 |
Wales | 25 |
West Midlands | 30 |
Yorkshire and the Humber | 32 |
Other | 16 |
Total | 1,190 |
Note: The ‘Other’ category includes companies based in the Channel Islands and companies that participated in an accelerator programme that mandated incorporation of the ultimate parent company in a non-UK jurisdiction.
The distribution of convertible loans made by the Future Fund broadly follows the pattern of equity investment across the UK. The British Business Bank’s 2020/21 Small Business Finance Markets report showed that companies outside London received 44% of equity investment by value in 2020. In the case of the Future Fund, 41% of loans by value were advanced to companies based outside London. As a rules-based scheme, the Future Fund was not set up to address disparities in equity finance across regions. All valid applications were approved, regardless of the location of the company.
Of the 158 companies converted as of 31 August 2021, 68 (43%) were based outside London. No reliable conclusions can be drawn from the small number of conversions that have taken place so far.
The government is providing the fastest ever sustained uplift in R&D funding, reaching £20bn per annum by the end of the SR period – £5bn more than 2021/22.
The significant rise in public R&D spending to £20bn by 2024/25, with a clear commitment to £22bn by 2026/27, provides a firm foundation for us to reach the target, but we cannot achieve it alone: it is only by working with innovative businesses and funders from the private sector that we will reach 2.4%. The government is doing its bit to reach the target, with record levels of public sector investment and a generous R&D tax credits scheme. Total government support for R&D (expenditure and R&D tax credits) is forecast to rise from 0.7% of GDP in 2018 to 1.1% in 2024-25, which is well above the latest OECD average of 0.7%.
We have set out our approach to attract increased private investment, for example in the R&D Roadmap last year and in the Innovation Strategy this year.
The UK is a world leader in Mathematics. British mathematicians publish a large volume of highly regarded work. When compared to international colleagues, British mathematicians have the 5th largest share of publications in the world. When looking at the top 1% of most cited publications, UK mathematicians are responsible for the third largest share.
Between Financial Year 2015-2016 and September 2021, EPSRC committed £259.9m to research grants Mathematical Sciences. This includes commitment from the Additional Funding Programme. At this current time, EPSRC are unable to make a direct comparison to international averages.
Following the Government’s announcement in January 2020 to invest additional funding into Mathematical Sciences, UKRI has awarded around £104 million of additional funding to the discipline, over and above EPSRC’s core Mathematical Sciences Theme budget. The additional funding has covered institutes, small and large research grants, fellowships, doctoral studentships and postdoctoral awards.
On the 27 October 2021, the Government announced the outcome of the Comprehensive Spending Review. BEIS and UKRI will now set out how we meet the commitment to invest additional funding into Mathematical sciences in forthcoming years, as part of the allocations process.
The UK is a world leader in Mathematics. British mathematicians publish a large volume of highly regarded work. When compared to international colleagues, British mathematicians have the 5th largest share of publications in the world. When looking at the top 1% of most cited publications, UK mathematicians are responsible for the third largest share.
Between Financial Year 2015-2016 and September 2021, EPSRC committed £259.9m to research grants Mathematical Sciences. This includes commitment from the Additional Funding Programme.
At this current time, EPSRC are unable to make a direct comparison to international averages.
Managing reactive power services is the responsibility of National Grid Electricity System Operator (NGESO). NGESO instructs generators or other asset owners to either absorb or generate reactive power.
NGESO periodically updates BEIS and Ofgem on this as part of our regular schedule of engagement to understand electricity system operability matters.
NGESO will publish its annual Operability Strategy Report by the end of the year, which considers system needs such as reactive power and how these needs will be met in the future.
The Government is keen to see that all postmasters whose Horizon convictions are overturned are fairly compensated as quickly as possible. On 22 July Government announced that it would be providing funding for Post Office to make interim payments of up to £100k to eligible postmasters who were subject to criminal proceedings linked to the Post Office Horizon IT system and whose Horizon convictions have subsequently been quashed. Only postmasters who have been subject to such proceedings are therefore eligible for these compensation payments.
The requested information is provided in the table below:
Location | Value of investment (£ millions) | Number of companies | Number of conversions |
London and the South East | 774 | 780 | 114 |
The North East | 27 | 30 | 2 |
The United Kingdom | 1,137 | 1,190 | 173 |
The Government is providing the fastest ever sustained uplift in R&D funding, reaching £20bn per annum by the end of the SR period – £5bn more than 2021/22. We remain committed to the target of UK economy-wide R&D investment reaching 2.4% of GDP by 2027. The UK already has world-class science and research and is ranked as one of the most innovative countries in the world.
The UK Shared Prosperity Fund (UKSPF) will help people access opportunity in places in need, such as ex-industrial areas, deprived towns and rural and coastal communities, and for people in disadvantaged groups across the UK.
Further details on the UKSPF will be published in due course.
The record level of investment announced for the UK research base at the Spending Review lays the strong foundation to realise our ambition to make the UK the most exciting place in the world for top research and innovation talent.
In July, the Government published the R&D People and Culture Strategy, which sets out our actions to attract, retain and develop talented people, making sure R&D careers in the UK are appealing to talented individuals and teams both domestically and internationally. This includes reviewing restrictions and costs and developing our understanding of the impact of the cost of moving to the UK on researchers, their teams and their families.
In line with the strategy, we are working with the Home Office to drive reforms to improve high skilled migration routes for innovators, entrepreneurs and top talent and we are working with the Office for Talent to launch an online service to attract highly skilled, international talent.
The record level of investment announced for the UK research base at the Spending Review lays the strong foundation to realise our ambition to make the UK the most exciting place in the world for top research and innovation talent.
In July, the Government published the R&D People and Culture Strategy, which sets out our actions to attract, retain and develop talented people, making sure R&D careers in the UK are appealing to talented individuals and teams both domestically and internationally.
In line with the strategy, we are working with the Home Office to drive reforms to improve high skilled migration routes for innovators, entrepreneurs and top talent and we are working with the Office for Talent to launch an online service to attract highly skilled, international talent. The strategy recognises the need to identify skills gaps, anticipate future needs, and ensure we have the workforce the UK needs, and commits to action to support STEM education and careers.
The budget for the Advanced Research & Invention Agency is included in the Department for Business, Energy and Industrial Strategy R&D budget set out in Table 2.2 of the Autumn Budget and Spending Review 2021 Red Book. For the 2024-25 budget, this is included in the £20bn.
The record level of investment announced for the UK research base at the Spending Review lays the strong foundation to realise our ambition to make the UK the most exciting place in the world for top research and innovation talent.
In July, the Government published the R&D People and Culture Strategy, which sets out our actions to attract, retain and develop talented people, making sure R&D careers in the UK are appealing to talented individuals and teams both domestically and internationally. It recognises the need to identify skills gaps, anticipate future needs, and ensure we have the workforce the UK needs, and commits to action to support STEM education and careers.
In line with the strategy, we are working with the Home Office to drive reforms to improve high skilled migration routes for innovators, entrepreneurs and top talent, and we are working with the Office for Talent to launch an online service to attract highly skilled, international talent.
The Global Britain Investment Fund (GBIF) will provide grants to encourage internationally mobile companies to invest in the UK’s critical and most innovative industries, where the UK has natural strengths and geographic spread. For example, the GBIF will cover the automotive sector, which has key regional clusters in the West Midlands, North West, and North East, as well as the life sciences sector, which currently has two thirds of jobs already located outside of London and the South East. Also included is the offshore wind sector, which is attracting significant new investment to our coastal communities, including floating offshore wind in Scotland and Wales.
Table 2.2 of the Autumn Budget and Spending Review 2021 Red Book relates to departmental R&D budgets.
Funding for the Advanced Research & Invention Agency is R&D spend and has its own ringfence, so does not come from either the Core Research or Innovate UK ringfences listed in table 2.2.
Funding for Help to Grow, and the Future Fund: Breakthrough is not R&D spend and they will be funded from the Programme and Financial Transactions Capital budget respectively.
We understand this question to be based on the Table 2.2 of the Autumn Budget and Spending Review 2021 Red Book which refers to overall Government R&D expenditure. In which case only a) Core Research, b) Innovate UK and c) EU Programme Association are relevant to BEIS.
The Core Research ringfence was only established by HM Treasury at the 2020 Spending Review. As a result we do not have an exact historical comparison over the last five years, but the majority of this funding is made up of UKRI Council funding. UKRI publishes details of its expenditure by Council, including Innovate UK, in its Annual Report and Accounts, which can be found in the House of Commons Library.
BEIS has allocated £1.3billion to fund EU programmes in 2021/22. Previously this was funded directly by HMT as part of our membership of the European Union
The Resource DEL outturn for all BEIS spend over the last five years was as follows;
£(m) | 2015-16 | 2016-17 | 2017-18 | 2018-19 | 2019-20 | 2020-21 |
Non-ringfenced | 2,224,853 | 1,606,596 | 1,447,538 | 934,592 | 2,506,905 | 25,989,881 |
Ringfenced | 268,978 | 355,397 | 266,467 | 310,652 | 331,470 | 275,918 |
Total | 2,493,831 | 1,961,993 | 1,714,005 | 1,245,244 | 2,838,375 | 26,265,799 |
Please note that 2020/21 figures have yet to be signed off by the annual audit process and may be subject to change
The Global Britain Investment Fund will be funded from a variety of sources, but funding will not come from either the Core Research or Innovate UK ringfences.
Officials from BEIS and UKGI meet regularly with Post Office and their legal representatives to discuss Horizon related issues. These discussions have included issues related to interim compensation payments.
The policy lead for the semiconductor sector rests with my Rt. Hon. Friend the Secretary of State for Digital, Culture, Media and Sport.
Software vendors need to apply to be part of the Help to Grow Digital Scheme. The vendor eligibility criteria for wave 1 was published on 29 July and is available at https://www.gov.uk/guidance/help-to-grow-digital-apply-to-become-a-vendor. The eligibility criteria is designed to ensure that small and medium businesses benefit from high-quality products. Eligible vendors must match the best market price available for their software and offer the same incentives such as trial periods and temporary discounts.
The Post Office has received 57 applications for interim payments. Post Office has made offers in 52 cases and made 43 payments so far. Other claims are progressing. Payments made to date have all been for maximum amount of £100,000. There have been 3 cases where interim payments were declined. Applications for interim payments are considered on a case-by-case basis. Individuals can pursue claims should they wish irrespective of whether or not they receive an interim payment.
Officials from BEIS and UKGI meet regularly with Post Office and their legal representatives to discuss Horizon related issues. These discussions have included issues related to interim compensation payments. The application form for interim compensation payment allows postmasters to provide details to Post Office of any issues, which may include hardship, that they consider Post Office should take into account when assessing an application.
An agency worker can qualify for equal treatment after working for 12 weeks in the same role with the same hirer. From April 2020 the Government banned the use of “Swedish Derogation” contracts. This ensures that agency workers cannot be pressured to opt out of their right to equal pay with permanent counterparts after the twelve-week qualifying period in the same role with the same hirer. While I cannot comment on individual cases, if somebody believes these requirements have not been met then it is open to them to seek redress through the Employment Tribunals system.
Ofgem estimate that 255,000 domestic customers and a small number of non-domestic customers are affected by Green Energy Company exiting the retail energy market. Ofgem runs the Supplier of Last Resort process with the aim of getting the best deal for consumers.
BEIS Ministers have not met with Green Energy Company employees. Energy suppliers have a duty to inform both Ofgem and their employees before exiting the market. Government help and support, including training and finding new employment is delivered by the Job Centre Plus Rapid Response Service and is available to all employees affected by energy suppliers exiting the market. For more information on government support visit the gov.uk website at https://www.gov.uk/guidance/redundancy-help-finding-work-and-claiming-benefits.
My Rt. Hon. Friend the Secretary of State and I held a roundtable on 21 September 2021 with smaller and challenger energy suppliers, including Green Energy Company. It is Ofgem, the independent regulator responsibility to engage with suppliers considering exiting the market.
In a competitive market, it is normal from time to time for energy suppliers who cannot finance their activities to exit the retail energy market.
On 20 September 2021 a roundtable was held with leading energy suppliers and consumer groups to hear about the challenges they currently face, and on 21 September a roundtable was held with smaller and challenger energy suppliers.
The Government wants to see a diverse energy market with many smaller and challenger energy suppliers bringing an improvement to customers. The biggest danger to a diverse market is the threat of renationalisation which would raise prices and damage investment.
My Rt. Hon. Friend the Secretary of State and I held a roundtable on 21 September 2021 with smaller and challenger energy suppliers, including Green Energy Company.
In the coming days, the Government will set out the next steps for protecting consumers, businesses and energy suppliers from these global price rises.
Where international traders trade in or target their activities at the UK, they are generally subject to UK consumer protection law and consumers are able to rely on a strong set of consumer rights. The UK Government does not hold information on the commercial arrangements of international couriers or international retailers. The Government is seeking to enhance global cooperation on consumer protection, through our trade policy and the Competition and Markets Authority’s work in international fora.
Where international traders trade in or target their activities at the UK, they are generally subject to UK consumer protection law and consumers are able to rely on a strong set of consumer rights. The UK Government does not hold information on the commercial arrangements of international couriers or international retailers. The Government is seeking to enhance global cooperation on consumer protection, through our trade policy and the Competition and Markets Authority’s work in international fora.
The Government’s investment was not predicated on OneWeb’s ability to provide PNT services. Future generations of OneWeb satellites may have the ability to enhance the resilience of a sovereign UK PNT system, together with terrestrial options.
The North East Local Enterprise Partnership and Tees Valley Combined Authority are jointly working to promote the scheme via local press, social media, e-newsletters, their websites, and targeted campaigns. The Made Smarter Adoption model is being independently evaluated through the Made Smarter North West Pilot, which ran from 2019 to 2021.
The Department is in regular communication with the Information Commissioner’s Office and other interested parties on matters relating to competition. We are currently consulting on the design of a new digital competition regime including new powers for the CMA to tackle problems in digital markets. BEIS is working with DCMS, ICO and others to ensure coherence across the work of different regulators.
The CMA is independent from Government and so BEIS did not contribute to the specific report on ‘Algorithms: How they can reduce competitions and harm consumers’.
The Department has assessed the benefits of SMEs increased adoption of technology, including evidence set out in the HMG Business Productivity Review, that strongly suggests that the productivity gains of technology adoption are likely to be significant. As such, I believe the scheme will provide a high degree of value for money and we will carry out robust monitoring and evaluation work to ensure this.
Software vendors need to apply to be approved onto the Help to Grow Scheme, which includes eligibility criteria designed to ensure that SMEs benefit from high-quality products. Approved vendors will need to provide SMEs with a clear pricing structure that is consistent between their advertised price and Help to Grow: Digital price and will need offer the same level of discounts or trial period and other incentives to SMEs as advertised to its other customers.
BEIS is making £0.6m of funding available for Made Smarter Adoption support for SME manufacturers into the North East which will play a crucial role in delivering key BEIS and Government objectives.
This funding will support recovery and resilience following Covid-19; create long term growth for manufacturers by driving productivity and competitiveness and encourage more firms to get on the road to innovation; support levelling up across the North East and help drive down carbon emissions from manufacturing sectors.
The £0.6m funding will enable around 100 manufacturing SMEs in this region to gain increased awareness of industrial digitalisation with 88 in the region being able to access intensive advice. This is projected to generate a net GVA increase of £3.1m and in turn generate a discounted Net Social Benefit (NSB) of £1.9m. There will not be separate ring-fenced funding allocations for (a) small and (b) medium sized firms.
Helping to protect the income of Postmasters is important to the department and we welcome the improvements outlined in the Mails Distribution Agreement (MDA).
The improvements will mean that whenever Royal Mail put up customer prices, Postmasters will see the benefit – with interim tariff payments for price increases earlier this year already being paid to Postmasters.
The Department has considered research, including the Government’s Business Productivity Review and from the Enterprise Research Centre and Office for National Statistics, which shows that technology adoption is strongly linked with significant productivity growth.
Dedicated communications and marketing activity to promote the Help to Grow Digital scheme and the benefits of technology adoption will commence when the scheme launches in Autumn 2021.
Help to Grow: Digital will launch in Autumn 2021 and therefore has not disbursed any funds to date. It is expected to disburse £296 million over three years up to 2024/25.
Help to Grow: Management delivered its first course on 5 July. The total cost of the programme is £220 million up to 2024/25. Approximately £62 million of this funding is expected to be disbursed in 2021/22.
Over the next three years, Help to Grow: Digital will support up to 100,000 small and medium-sized businesses with online advice and a voucher to help meet software costs.
Help to Grow: Management will support up to 30,000 small and medium-sized businesses leaders from across the UK to increase productivity, seize investment opportunities and grow their business.
Help to Grow: Digital has a budget of £296 million over the three years of the scheme.
Help to Grow: Management has a budget of £220 million over the next three years.
The effectiveness of both Help to Grow programmes will be assessed on the productivity benefits gained by SMEs, and early indicators of success based on criteria such as successful tech adoption and increased use of management practices within their business. Data on the geographical spread of participating SMEs, and their outcomes, will be part of the monitoring and evaluation.
Delivery charges are agreed between the retailer and the delivery/courier company. These are commercial decisions. We already have robust consumer legislation in place to ensure that when making a purchase online, retailers provide clear and upfront information about delivery charges and restrictions before the consumer makes a purchase. Breaches of the legislation should be reported in the first instance to the Citizens Advice consumer service on 0808 223 1133, or https://www.citizensadvice.org.uk/consumer/.
The Government does not comment on the detail of commercial transactions.
Future Fund: Breakthrough will encourage private investors to co-invest with government in high-growth, innovative firms.
The fund will provide equity funding to innovative, R&D-intensive UK companies operating in breakthrough technology sectors, including life sciences. The process of securing Future Fund: Breakthrough funding is demand-led: lead investors must apply to the Fund on behalf of the company seeking investment. There are no ringfences for particular sectors.
Last year, we published our ambitious Research and Development Roadmap, setting out our long-term vision for the R&D system, including cutting unnecessary bureaucracy, embracing diversity in the R&D workforce, levelling up across the UK, embracing innovation, and boosting international collaboration.
This year we are investing £14.9 billion in research and development in 2021/22 across government, putting UK Government R&D spending at its highest level in four decades.
The next Spending Review will set out plans for future R&D funding. Our investment in R&D will support our Roadmap commitments and helps consolidate our position as a science superpower, as we build towards increasing public expenditure on R&D to £22bn and delivering on our target to increase total UK R&D investment to 2.4% of GDP by 2027.
An Independent Fan Led Review of Football Governance chaired by my Hon. Friend the Member for Chatham and Aylesford (Tracey Crouch MP) is underway with its work. It is a root-and-branch examination of football in this country, looking at the financial sustainability of the football pyramid, governance regulations, and the merits of an independent regulator. It will also consider the current Owners’ and Directors’ test, and the transparency and accountability of that process.
Responsibility for investigating individual and market-wide competition issues falls to the Competition and Markets Authority (CMA), the UK’s competition authority. As an independent authority, it is for the CMA to decide which cases to investigate, which it does according to its prioritisation principles. The CMA may also carry out detailed examinations of why particular markets may not be working well and take remedial action to address features of markets which restrict competition. It is for the CMA to determine the information to be published regarding the discharge of its regulatory functions.
On Monday 5 July, my Rt. Hon. Friend the Prime Minister set out the details of the final stage of the roadmap and our approach for managing Covid as we learn to live with the virus. The ‘Working Safely’ guidance was updated on 14 July in advance of moving to step 4. Isolation remains the most important action people can take to stop the spread of the virus. It is crucial people isolate immediately when they are told to do so. Businesses should be supporting employees to self-isolate.
From 16 August, those who are fully vaccinated will no longer be required to self-isolate if they are a close contact of a positive case. Instead, they will be advised to take a PCR test. Until these changes come into effect, it is essential that everyone continues to observe the rules to protect those who are not yet fully vaccinated or are clinically vulnerable. Anyone who tests positive will still need to self-isolate regardless of their vaccination status.
In order to protect the delivery of public services, a very limited number of named critical workers will be informed that they are considered to have reasonable excuse to leave self-isolation if they are contacts. This will only apply to workers who are fully vaccinated (someone who is 14 days post-second dose) and is solely for the purpose of going to work.
This is a small and targeted intervention, enabling individuals to attend work where not doing so would lead to major detrimental impact on the availability, integrity or delivery of essential services – including services whose integrity, if compromised, could result in significant loss of life or casualties, and/or attend work where not doing so would result in significant impact on national security, defence, or the functioning of the state.
The analysis of final Coronavirus loan scheme data was published on July 6, 2021 on the British Business Bank website.[1]
Under the Coronavirus Business Interruption Loan Scheme, 136 loans were delivered in the Newcastle upon Tyne Central constituency, to the sum of £47,292,585. The average value of loan was £347,739.59.
Under the Bounce Back Loan Scheme, 2,635 loans were delivered in the Newcastle upon Tyne Central constituency to the sum of £81,819,93. The average value of loan was £3,105.12.
An Independent Fan Led Review of Football Governance, chaired by my Hon. Friend the Member for Chatham and Aylesford (Tracey Crouch MP) is underway . It is a root-and-branch examination of football in this country, looking at the financial sustainability of the football pyramid, governance regulations, and the merits of an independent regulator. It will also consider the current Owners’ and Directors’ test, and the transparency and accountability of that process.
Responsibility for investigating individual and market-wide competition issues falls to the Competition and Markets Authority (CMA), the UK’s competition authority. As an independent authority, it is for the CMA to decide which cases to investigate, which it does according to its prioritisation principles. The CMA may also carry out detailed examinations of why particular markets may not be working well and take remedial action to address features of markets which restrict competition. It is for the CMA to determine the information to be published regarding the discharge of its regulatory functions.
We are aware of the takeover of Newport Wafer Fab by Nexperia, and the Government has been in close contact with Newport Wafer Fab throughout.
We are unable to comment on the detail of commercial transactions, or of national security assessments. The Government will continue to monitor the situation closely and will not hesitate to take action if needed.
The smart metering Data Access and Privacy Framework protects consumers’ privacy and set outs the levels of access to energy consumption data from smart meters permitted for different parties. The Framework ensures that households have control over who can access their energy consumption data and for what purposes, except where this is required for regulated purposes.
Energy suppliers and networks are permitted under their Licence Conditions to access energy consumption data for narrowly defined regulatory purposes.
Energy suppliers can access data for purposes including billing, meeting a customer request for access to their data, responding to an enquiry or complaint by a customer, and where they have reasonable grounds to suspect and investigate theft.
Energy networks can access granular consumption data to support the safe and efficient management and reinforcement of energy networks, provided they have a consumer’s consent or implement strict data protection procedures approved by Ofgem.
Information must be made available to consumers on which energy consumption data will be accessed and for what purpose.
An Independent Fan Led Review of Football Governance chaired by my Hon. Friend the Member for Chatham and Aylesford is underway with its work. It is a root-and-branch examination of football in this country, looking at the financial sustainability of the football pyramid, governance regulations, and the merits of an independent regulator. It will also consider the current Owners’ and Directors’ test, and the transparency and accountability of that process.
Under competition law, responsibility for investigating individual and market-wide competition issues falls to the Competition and Markets Authority (CMA), the UK’s competition authority. The Government has ensured that the CMA has significant powers and expertise to investigate and take action against businesses that abuse dominant positions in markets, for instance, by unfairly excluding competitors or exploiting consumers. In the regulated sectors, these competition powers are also exercisable by the relevant sector-specific regulators. The CMA may also carry out detailed examinations of why particular markets may not be working well and take remedial action to fix features of markets which restrict competition. Most sector-specific regulators in monopoly sectors have a legal duty to promote competition for the benefit of consumers (or equivalent).
There has been Ministerial engagement throughout the UKRI open access review.
Ensuring open access policy is as permissive as possible for researchers whilst also achieving public value and affordability, and taking account of the changing landscape in publishing agreements in the UK are all key considerations of the review.
We will publish a comprehensive Net Zero Strategy ahead of COP26, setting out the Government’s vision for transitioning to a net zero economy. This will raise ambition as we outline our path to meet net zero by 2050, our Carbon Budgets and Nationally Determined Contribution (NDC).
BEIS is due to publish a new space weather strategy later this year. This will set out a five-year roadmap on the steps we will take to further enhance the UK’s resilience to major space weather events.
The Department is unable to provide a detailed breakdown of loan recipients under the Bounce Back Loan Scheme (BBLS) or the Coronavirus Business Interruption Loan Scheme (CBILS) as this information is commercially sensitive for borrowers.
Details of facilities made available under the schemes have been published where required by the European Commission’s Transparency Aid Module at the following website: https://webgate.ec.europa.eu/competition/transparency/public?lang=en.
However this data will only show the region where the business is located. Further information on data reporting can be found on the British Business Bank’s website: https://www.british-business-bank.co.uk/ourpartners/coronavirus-business-interruption-loan-schemes/data-reporting/.
As of 7 June 2021, the total number of loans taken up under the schemes by businesses in Newcastle Upon Tyne Central is as follows:
Scheme | Number of Loans | Value | Median Value |
BBLS | 2627 | £ 81,511,198 | £ 30,000 |
CBILS | 135 | £ 47,062,585 | £ 150,000 |
The UKRI Open Access Review has included a series of consultation stages and analysis. The final policy recommendations are now moving through the final agreement process and the outcomes of the Review will be published as soon as the process is complete. It is anticipated that these will be published this summer.
I recognise the pandemic’s impact on the research sector, and the ability of the research sector to adapt to any new arrangements has been an important consideration throughout the UKRI Open Access Review. I can assure you that this has been taken into account in the formation of the policy and implementation considerations.
For peer-reviewed research articles the proposed policy start date will be 1 April 2022, while the policy for monographs is proposed to start from 1 January 2024. UKRI will work closely with stakeholders in the lead up to the policy start dates to ensure any questions or issues are addressed.
The UKRI Open Access Review has included a series of consultation stages and analysis. The final policy recommendations are now moving through the final agreement process and the outcomes of the Review will be published as soon as the process is complete. It is anticipated that these will be published this summer.
I recognise the pandemic’s impact on the research sector, and the ability of the research sector to adapt to any new arrangements has been an important consideration throughout the UKRI Open Access Review. I can assure you that this has been taken into account in the formation of the policy and implementation considerations.
For peer-reviewed research articles the proposed policy start date will be 1 April 2022, while the policy for monographs is proposed to start from 1 January 2024. UKRI will work closely with stakeholders in the lead up to the policy start dates to ensure any questions or issues are addressed.
The Competition and Markets Authority is independent of the government, with a remit to tackle individual and market-wide competition issues, including breaches of competition law. The CMA is currently active in digital markets, but we intend to strengthen its ability to tackle digital competition issues. This why the Government committed in November 2020 to establish a new digital competition regime, to be overseen by a Digital Markets Unit within the CMA, to tackle the market power of dominant digital platforms. We will consult on the new regime and legislate to put the Digital Markets Unit on a statutory footing as soon as parliamentary time allows.
Smart meters are replacing traditional gas and electricity meters in Great Britain as part of an essential infrastructure upgrade to make the energy system more efficient and flexible, enabling the cost-effective delivery of net zero greenhouse gas emissions.
The Government has put in place a strict Data Access and Privacy Framework that protects consumers’ privacy and set outs the levels of access to energy consumption data from smart meters permitted for different parties. The Framework ensures that households have control over who can access their energy consumption data and for what purposes, except where this is required for regulated purposes (such as accurate billing).
Consumers can also choose to share their data with third parties for example to obtain tailored energy efficiency advice. Where third parties are accessing consumption data via the smart metering network they must have the consumer’s consent which consumers can withdraw at any time. In addition to the specific protections of the Framework, all parties are required to comply with relevant data protection laws when processing personal data.
On average, the Royal Society funds 30 new FLAIR fellowships per year through the Global Challenges Research Fund (GCRF). Thirty fellowships were awarded for the 2020 cohort, and these will continue receiving full funding throughout this year. The Royal Society will not be funding any new FLAIR fellowships for this year.
The purpose of the Inquiry is to understand and acknowledge what went wrong in relation to Horizon and to ensure that there is a public summary of the failings that occurred at Post Office Ltd. At the Inquiry’s outset its Terms of Reference were published, which can be found at: https://www.gov.uk/government/publications/post-office-horizon-it-inquiry-2020/terms-of-reference.
The Post Office Horizon IT Inquiry’s Terms of Reference state that the Inquiry will only consider the matters set out in its Terms of Reference.
All information relating to how funding allocations for business support grants is contained within guidance that has been issued to local authorities and which is available on GOV.UK. All allocations figures are also available on GOV.UK.
LRSG (Open) allocations to local authorities were based on a government estimate of the number of in-scope business premises. This drew on data provided by the Valuation Office Agency which gave the number of business hereditaments in the local rating lists in the relevant sectors by local authority. Local authorities were asked to use their own understanding of local businesses to determine eligibility. This was a discretionary scheme meaning central government did not mandate which businesses a local authority was required to support.
For the Additional Restrictions Grant (ARG) scheme, Local Authorities received an initial one-off lump sum payment amounting to £20 per head of residential population in each eligible Local Authority area when Tier 3 or widespread national restrictions in November were imposed, whichever was the earliest date. This calculation was based on ONS 2019 Mid-Year Population Estimate for the total population within a local authority. If an area agreed an enhanced package before National Lockdown, then that negotiated amount was honoured. A subsequent top-up to ARG of £500m in January 2021 was also based on the same calculation.
In March, my Rt. Hon. Friend Mr Chancellor of the Exchequer announced a further £425 million top up to ARG would be made available to those local authorities that had spent their initial two allocations. This tranche of ARG will be allocated on the basis of business population in an area, rather than residential numbers and will only be unlocked where expenditure requirements on the first two tranches are met.
The Restart Grants allocations have been made on the basis of an estimate of the number of business hereditaments in the specified sectors covered by the grant scheme. This estimate has been informed by Valuation Office Agency data on business hereditaments in the local rating lists, but local authorities are the decision makers on whether specific businesses are eligible or not. The Government paid 90% of this estimated total to Local Authorities and are committed to provide further top ups if required to cover all businesses in scope.
The Vaccine Taskforce brought onboard specialist communications support as contingent labour using the Public Sector Resourcing framework, rather than signing a contract with Admiral as a company. This contingent labour ceased involvement with the Vaccine Taskforce at the end of 2020.
Details of commercial arrangements with all firms and contract labour used by the Vaccine Taskforce have been published in line with the usual transparency arrangements.
The Government recognises the impact the pandemic has had on hospitality businesses including wet led pubs. That is why we have provided an unprecedented support package of £352 billion including grants, loans, business rates relief, VAT cuts and the job retention scheme. Pubs are eligible for our restart grants of up to £18,000 to help them recover and reopen.
The Government recognises the impact the pandemic has had on hospitality businesses including independent pubs. That is why we have provided an unprecedented support package of £352 billion including grants, loans, business rates relief, VAT cuts and the job retention scheme. In order to help pubs recover and reopen, we are providing restart grants of up to £18,000.
Our association to Horizon will give UK scientists and innovators access to the largest collaborative research funding scheme in the world.
The UK has agreed to participate in the whole of the Horizon Europe programme, except the European Innovation Council Fund.
The work programmes for parts of Horizon Europe have not been finalised by the EU, however under the Horizon Europe regulations, access to calls may be restricted to entities established in EU Member States in certain cases. We expect these cases to be exceptional.
We engage with the Commission on a range of topics relating to Horizon Europe, including supporting research collaboration between the UK and EU, timing of funding opportunities under Horizon Europe and potential exclusions.
Our association to Horizon will give UK scientists and innovators access to the largest collaborative research funding scheme in the world.
The UK has agreed to participate in the whole of the Horizon Europe programme, except the European Innovation Council Fund.
The work programmes for parts of Horizon Europe have not been finalised by the EU, however under the Horizon Europe regulations, access to calls may be restricted to entities established in EU Member States in certain cases. We expect these cases to be exceptional.
We engage with the Commission on a range of topics relating to Horizon Europe, including supporting research collaboration between the UK and EU, timing of funding opportunities under Horizon Europe and potential exclusions.
I am grateful to have the paper brought to my attention. The National Cyber Security Centre continue to focus on the security and reliability of computer systems and conduct research, working with research institutes, in order to maintain and develop current understanding.
It has not proved possible to respond to the Hon. Member in the time available before Prorogation.
It has not proved possible to respond to the Hon. Member in the time available before Prorogation.
It has not proved possible to respond to the Hon. Member in the time available before Prorogation.
In designing ARIA, we have considered international comparators including the Defense Research Projects Agency (DARPA) in the US. DARPA benefits from autonomy and flexibility outside the standard government contracting and granting standards. Flexibility is a core element of the DARPA model, and its history of success in the US.
ARIA is not intended to replicate DARPA - but DARPA has flexibilities that will benefit ARIA in the UK context.
On the basis the available data, which is limited to evidence from: Capital IQ on mergers and acquisitions with a value of £1 million and above; Pitchbook on transactions with a value below £1 million, and; Orbis on the number of indirect mergers and acquisitions, the removal of the 15% mandatory notification threshold from the National Security and Investment Bill is assessed as de minimis. Nonetheless, we do expect this to reduce the number of acquisitions subject to mandatory notification.
ARIA will have an open remit, with maximum autonomy over what it chooses to fund. Its focus will be on finding and funding transformational science and technology, wherever it exists.
ARIA’s budget commitment of £800m up to 2024/25 is expected to represent less than 2% of the Government’s current total annual R&D investment over the same period.
The numbers of Freedom of Information Act (FOI) requests received and completed since UK Research and Innovation (UKRI) was established in April 2018 are:
| 2018 | 2019 | 2020 | 2021 (January to March) |
FOI requests Received | 240 | 358 | 362 | 101 |
FOI responses Completed | 225 | 336 | 371* | 98 |
*cases received at the end of 2019 were closed in the beginning of 2020.
UKRI does not record the costs of responding to individual FOI requests.
ARIA is an addition to the public funding landscape and will exclusively focus on projects with potential to produce transformative technological change, or a paradigm-shift in an area of science.
ARIA will have an open remit, with maximum autonomy over what it chooses to fund. The additional funding stream will complement existing publicly or privately funded research for cutting edge science and technology. However, ARIA’s streamlined structure, minimal bureaucracy and financial flexibility will mean ARIA can fund this research in new and creative ways, delivering to researchers in the way that best supports their work.
We expect ARIA to be operational from Spring 2022.
ARIA’s leadership will have the autonomy to choose which programmes they fund and how they fund them to best deliver long-term, transformational advances in science and technology. As detailed in the ARIA Bill, in exercising its functions ARIA will have regard to the desirability of:
BEIS will not set specific criteria for strategic funding decisions or for the goals of Programme Managers.
The spending profile for ARIA will be for the leadership of ARIA to develop.
The Government has set out plans at Spending Review to cement the UK’s status as a global leader in science and innovation by investing £14.9 billion in R&D in 2021/22. This investment supports our commitments set out in the R&D Roadmap as we build towards UK R&D investment of 2.4% of GDP by 2027.
Leveraging investment from the private sector will be vital to reach the 2.4% target and achieve our ambitions for innovation. The Government has already set out at Budget a range of measures to boost private investment in research and development, including a review of R&D tax reliefs, supported by a consultation with stakeholders, and £375 million to introduce Future Fund: Breakthrough, a new direct co-investment product to support the scale up of the most innovative, R&D-intensive businesses.
The Government is also establishing the Advanced Research and Invention Agency (ARIA), focusing exclusively on high-risk, high-reward research with a budget of £800m up to 2024/25. ARIA projects will be able to attract private co-financing as part of a new and creative approach to funding.
These developments will complement our existing incentives for private R&D investment and, as the Plan for Growth set out at Budget, BEIS will also publish an Innovation Strategy this summer with a view to providing the private sector the confidence to invest as we look to Build Back Better.
ARIA is being established to pursue long-term research that has a transformational impact over many years. As it always has done, BEIS will continue to work with HM Treasury to manage multi-year commitments against fiscal budgeting cycles.
The open recruitment campaigns for ARIA’s first Chair and CEO will launch this spring and there is no intention to make any interim appointments.
I refer the Hon. Member to the reply I gave on 30th March 2021 to Question 173012.
Valuation Office Agency data identified the number of rate-paying businesses in scope for LRSG (Open) in the sectors and local authority areas where this scheme was applicable. This was done on the basis of Special Category (SCAT) code data which classifies properties by use.
In recognition that there are businesses, such as market traders, that aren’t on the business rates register, the Additional Restrictions Grant has been made available to Local Authorities to provide discretionary support to businesses including those t not on the business rates register.
The challenging financial situation we face due to the Covid-19 pandemic has resulted in a temporary reduction in the UK’s aid spending target from 0.7% of GNI to 0.5%. This means making difficult decisions when it comes to prioritising how we spend aid money to deliver the most impactful outcomes.
BEIS is working with its ODA Delivery Partners to manage the implementation of the 21/22 ODA settlement for R&D; this includes the Royal Society who run the FLAIR programme.
ARIA will fund research in new ways across areas, industries, or technologies. ARIA will not have its research focus set by Ministers. Following an open and robust recruitment process, my Rt. Hon. Friend the Secretary of State will appoint an exceptional and visionary leadership team and entrust them to set the research agenda for ARIA.
While ARIA will not be given an overarching ‘mission’ by Government, ARIA’s programmes will each be motivated by a single, clear ambition set by the programme manager. Research projects and funding decisions will all be motivated by that clear programme goal.
The Government is committed to continuing to provide financial support via Local Authorities for business premises that are required to close, or which are severely affected by the restrictions put in place to tackle Covid-19 and save lives.
For businesses in Tier 2 and Tier 3, funding was made available to Local Authorities to provide discretionary grants via the Local Restrictions Support Grant (LRSG) (Open). When the national lockdown was announced on 5 January, the LRSG (Open) was replaced by the LRSG (Closed) Addendum: 5 January onwards. From 1 April, the LRSG will be replaced by Restart Grants to support businesses as they begin to reopen.
Discretionary grants – the LRSG (Open) and the Additional Restrictions Grant (ARG) - are formula based. Data on Government allocations to, and payments by, Local Authorities, of the LRSG (Open) and other Government Business Support Grants, is available at: https://www.gov.uk/government/publications/coronavirus-grant-funding-local-authority-payments-to-small-and-medium-businesses.
The link provided in the answer given to Question 162599 was a link to local authority level allocations summary which required you to click through to the guidance released on the methods for calculating allocations for the Additional Restrictions Grant and Local Restrictions Support Grant (Open). The direct links to the relevant guidance is as below.
For the Additional Restrictions Grant (ARG), guidance sets out the original method for allocating funds: ‘Local Authorities will receive a one-off lump sum payment amounting to £20 per head in each eligible Local Authority when LCAL 3 or widespread national restrictions are imposed.’
For the Local Restrictions Support Grant (Open) covering the periods of local restrictions between 1st August to 5th November and 2nd December to 5th January the guidance sets out that funding was allocated on the basis of Valuation Office Agency data on the number of businesses in scope in those areas of England subject to local Covid restrictions for the period in question.
Guidance for the 1st August to 5th November period can be found here:
Guidance for the 2nd December to 5th January period can be found here: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/966858/20210304_Local_Restrictions_Support_Grant__OPEN__applicable_2_December_-_LA_guidance.pdf.
In the single year Spending Review covering financial year 2021-2022, the Government committed to provide the first £50 million in funding for ARIA related activities, and a total £800 million investment by 2024-25.
The precise year-on-year allocations for ARIA after 2021-22 will be determined for, and announced in, forthcoming Spending Reviews.
BEIS officials have been working on the high-level design features of ARIA to support delivery of the ARIA Bill, and delivery of a forthcoming framework agreement between ARIA and BEIS. This said, it is by design that certain operational details are left at the discretion of the independent body.
The Government is monitoring the impact of COVID-19 on private sector research and development through surveys - such as the Enterprise Research Centre’s work on the impact of the COVID-19 crisis on the status of Innovate UK award holders, published at https://www.enterpriseresearch.ac.uk/publications/assessing-the-impact-of-covid-19-on-innovate-uk-award-holders-survey-and-case-study-evidence-wave-2-october-november-2020/ .
Office for National Statistics data on R&D performed in UK Businesses in 2020 is planned for release toward the end of 2021. This will help us to assess the effect of the pandemic on R&D investment levels.
We remain committed to increasing UK investment in R&D to 2.4% of GDP by 2027. The Government set out plans at Spending Review to invest £14.6 billion in R&D in 2021/22.
Leveraging investment from the private sector will be vital to reach the 2.4% target and achieve our ambitions for innovation. The Government has already set out at Budget a range of measures to boost private investment in research and development, including a review of R&D tax reliefs, supported by a consultation with stakeholders, and £375 million to introduce Future Fund: Breakthrough, a new direct co-investment product to support the scale up of the most innovative, R&D-intensive businesses. These developments will complement our existing incentives for private R&D investment.
As set out in ‘Building Back Better: our Plan for Growth’, we are developing an Innovation Strategy, which will be published in the summer. The Strategy will consider how we can boost innovation across the UK economy to increase productivity and tackle our biggest social and economic challenges.
In order to maximise the economic and environmental opportunities of the transition to zero emission vehicles, the UK Government is supporting the creation of a circular economy for electric vehicle batteries.
This includes supporting the innovation, infrastructure, and regulatory environment for a UK battery recycling industry, including reuse in second life applications (such as energy storage) and development of efficient recycling techniques to extract maximum value.
The Government has allocated £318m to the Faraday Battery Challenge which is playing a leading role in promoting the reuse and recycling of battery components. The Faraday Institution’s £10 million ‘ReLib’ (Reuse and Recycling of Lithium-ion Batteries) research project is developing the technological, economic and legal infrastructure to allow high percentages of the materials in lithium-ion batteries at the end of their first life to be reused or recycled.
The Automotive Transformation Fund has been designed to support strategic investments in the electric vehicle supply chain, the scope of which includes battery recycling facilities.
Research and development (R&D) are central to igniting the UK’s economic recovery, creating new jobs, boosting productivity, and improving people’s quality of life. New technologies will bring more productive, higher paid jobs to the whole economy.
We are increasing investment in R&D across government to £14.6bn in 2021/22. This investment will put research and development at the heart of economic and social recovery from the impacts of COVID-19, enabling us to build back better for a greener, healthier and more resilient UK.
We are working closely with all our delivery partners to understand the impact of the settlement on universities and other research institutions. We are also engaging with our partners to develop the 2021/22 allocations and help them plan implementation.
We aim to update our partners on 2021/22 funding as soon as possible.
Research and development (R&D) are central to igniting the UK’s economic recovery, creating new jobs, boosting productivity, and improving people’s quality of life. New technologies will bring more productive, higher paid jobs to the whole economy.
We are increasing investment in R&D across government to £14.6bn in 2021/22. This investment will put research and development at the heart of economic and social recovery from the impacts of COVID-19, enabling us to build back better for a greener, healthier and more resilient UK.
We are working closely with all our delivery partners to understand the impact of the settlement on universities and other research institutions. We are also engaging with our partners to develop the 2021/22 allocations and help them plan implementation.
We aim to update our partners on 2021/22 funding as soon as possible.
The Government engages closely with businesses and local partners to understand the impact of Covid-19 across all sectors of the economy.
Substantial grant support has been made available throughout the pandemic including to those businesses with a rateable value of £51,000 and above.
Where those businesses are currently required by law to close, the Local Restrictions Support Grant enables local authorities to make grant payments of the equivalent of £4,500 per six-week period of closure.
Businesses with a rateable value above £51,000 that were required by law to close at the beginning of the January lockdown are also able to access one-off grants of £9,000 through the Closed Business Lockdown Payment.
My Rt. Hon. Friend Mr Chancellor of the Exchequer has announced that a further iteration of grants will be made available to enable businesses to reopen as Covid-19 restrictions are lifted. Restart Grants will offer businesses further one-off grants of up to £18,000. Further details will be made available in due course.
BEIS has received a one-year Spending Review settlement along with all other departments. The Investment Security Unit will have the necessary resources to deliver the National Security and Investment regime.
Great Britain has one of the most robust energy systems in the world and maintaining a secure electricity supply is a key priority for the Government.
The Department works extensively with National Grid Electricity System Operator (NGESO) and other infrastructure operators, to ensure that the impacts of a severe space weather event are well understood, and the appropriate steps are taken to ensure the sector’s preparedness for major space weather events.
NGESO has robust plans in place, which are constantly reinforced based on the latest science and information, to mitigate against high impact risks, including solar storms. In recent years, National Grid has increased the number of spare transformers that they hold so that damaged equipment can be promptly replaced, continue to introduce a new design of transformers which are operationally more resistant to the effects of space weather and undertaking emergency exercises aimed at improving knowledge, resilience, and response capability.
In order to improve our ability to predict and mitigate the hazards of space weather, in October 2019 the UK Government announced a £20m boost to predict severe space weather events. This nearly quadruples investment from government into research that can improve systems at the Met Office Space Weather Operations Centre. This will further build the UK’s knowledge on how to forecast and better prepare for these space weather events.
Early in the existence of the Vaccine Taskforce, public communication on vaccines was identified as a key challenge for the successful delivery of COVID-19 vaccines. The Government strengthened its communication function to support this significant undertaking and communication specialists sourced by Admiral (with experience in clinical trials and of working with the National Institute for Health Research (NIHR)) were brought onboard using the Public Sector Resourcing framework.
The communication specialists sourced by Admiral worked with the NIHR to develop the world’s first national citizen registry so that individuals could sign up to participate in clinical vaccine trials. As a result, over 454,000 people have signed up to date.
Admiral was also involved in creating a proactive communications programme aimed at encouraging greater sign-up to the registry through the “COVID-19: the search for a vaccine” podcast. This provided a factual transparent source of information on vaccines for UK citizens, combating the anti-vaccination movement, and highlighting the UK's role as a leader in vaccine research and development. The podcast included an episode that specifically covered the need to include people from the Black, Asian and ethnic minority communities in trials and addressed some of the concerns within these communities.
The Investment Screening Unit (ISU) will have the necessary resources to deliver the National Security and Investment regime and will draw on expertise and skills held across government and security services.
The Government understands the role data plays in delivering benefits in the public and private sectors and the UK has traditionally maintained high quality address data that supports a wide range of uses across the economy.
The Postcode Address File (PAF), owned and maintained by Royal Mail Group, is the definitive list of postal delivery points for the UK and a key enabler of the Universal Service Obligation.
The PAF provides access to the private sector on reasonable terms, which are regulated by Ofcom, with free access to small charities and microbusinesses in their first year. On 1 April 2020, the Government extended the PAF Public Sector Licence for a further 3 years to ensure free at the point of use access to PAF data for all public sector organisations to support the delivery of effective and efficient public services.
UK Research and Innovation has made commitments totalling £100m from within this programme to date. £8m of this is currently allocated for this financial year. This includes £1.76m for PhD Studentships, the first cohort of which had 146 PhD students starting in October 2020 with 29% of these supported under increased residency eligibility flexibility afforded to international students.
The UK is a world leader in space weather forecasting and the Met Office Space Weather Operations Centre provides forecasts and warnings of space weather on a 24/7 basis.
Coronal Mass Ejections (CMEs) are responsible for the most severe space weather. Preliminary warnings are issued at least 12 hours in advance for the fastest CMEs. Certainty over the magnitude of an event and its impacts is dependent on critical measurements as the CME passes over monitoring spacecraft positioned 1 million miles from Earth and is provided with approximately 15 to 20 minutes notice. The UK is the largest funder of the European Space Agency “Lagrange” mission, which is due to launch in 2027. This mission will enable better characterisation of CMEs and improve forecasting accuracy of the timing and magnitude of events.
International collaboration is crucial to space weather prediction. The UK’s primary partners are the NOAA Space Weather Prediction Centre and the USAF 557th Weather Wing in the United States, with whom the Met Office maintains 24/7 communications in support of our respective operations. The UK also collaborates closely with many nations in Europe notably Belgium, Finland, the Netherlands and Germany.
As of 3rd March 2021, £84 million had been awarded to organisations registered in the North East, out of a total of £1.8 billion of grants awarded from the Industrial Strategy Challenge Fund across the whole of the UK.
The Government has provided funding to establish Centres of Excellence for vaccines to expand the UK’s manufacturing capacity and associated advanced therapeutics. The aim is to respond to this pandemic as well as increase the UK’s pandemic preparedness for the future.
Investments which will contribute to our future preparedness include:
The Government is committed to making the UK the top destination in the world for scientist, researcher and innovator talent. That is why in the 2021 Budget, the Government announced planned changes to the UK immigration system to help the UK attract and retain the most highly skilled, globally mobile talent from around the world and ensure the continued competitiveness of our high-growth, innovative sectors. These changes include the introduction of an elite points-based visa, a review of the Innovator visa route, and reforms to the Global Talent visa, including to allow recipients of international prizes to automatically qualify.
We are working closely with the Home Office on these matters, and my Rt. Hon. Friend the Secretary of State for Business, Energy and Industrial Strategy speaks regularly with my Rt. Hon. Friend the Home Secretary to discuss our plans for growth and to build back better, of which these immigration announcements are key components.
Further details on the policies and impact assessments will be published in due course. The Government expects these immigration changes to attract an additional 10-20,000 high-skilled migrants to the UK per year across all high-skilled routes to turbo-charge our post pandemic recovery and stimulate the UK’s longer-term growth.
As set out in ‘Building Back Better: our Plan for Growth’, we are developing an Innovation Strategy, which will be published in the summer. The Strategy will consider how we can boost innovation across the UK economy to increase productivity and tackle our biggest social and economic challenges.
The Government has set out plans at Spending Review to cement the UK’s status as a global leader in science and innovation by investing £14.6 billion in R&D in 2021/22. This investment supports our commitments set out in the R&D Roadmap as we build towards UK R&D investment of 2.4% of GDP by 2027.
Leveraging investment from the private sector will be vital to reach the 2.4% target and achieve our ambitions for innovation. The Government has already set out at Budget a range of measures to boost private investment in research and development, including a review of R&D tax reliefs, supported by a consultation with stakeholders, and £375 million to introduce Future Fund: Breakthrough, a new direct co-investment product to support the scale up of the most innovative, R&D-intensive businesses. These developments will complement our existing incentives for private R&D investment.
The methodology for calculating grant allocations for the discretionary business grant funds has been published in Government guidance for Local Authorities which is available at: https://www.gov.uk/government/publications/coronavirus-grant-funding-local-authority-payments-to-small-and-medium-businesses.
There are two discretionary schemes which have been available for specified periods from August 2020 - the Local Restrictions Support Grant (Open) and the Additional Restrictions Grant.
For the Local Restrictions Support Grant (Open), applicable between the 1 August- 5 November 2020 and between 5th December 2020 and 5th January 2021, in areas where local Covid-19 restrictions were in place, the relevant Local Authorities were issued funding allocations which were calculated using Valuations Office Agency (VOA) data on the number of hospitality, accommodation and leisure businesses in the Local Authority geography, plus a 5% top up.
For the Additional Restrictions Grant, the initial allocation and subsequent additional allocations were based on ONS 2019 Mid-Year Population Estimate for the total population within a given Local Authority.
The UK will participate in Horizon Europe as part of the Trade and Co-operation Agreement (TCA) with the EU. We will pay a fair and appropriate share into the budget of this programme to enable the UK science and research sector to further their partnerships with our European neighbours.
Participating in Horizon Europe will strengthen R&D to build on the UK’s world class reputation for research and innovation. It provides exciting opportunities for UK businesses and SMEs to support growth and innovation, working with our international partners. Business organisations and researchers have strongly welcomed us securing this outcome.
We will set out our plans for R&D spend in 2021/22 – including funding for Horizon Europe – when we publish our R&D allocations. This will be done in due course.
The UK was the first country in the world to procure, authorise, and start a vaccination programme using the Pfizer/BioNTech and Oxford/AstraZeneca vaccines. The Government has secured access to 457 million doses, across eight different vaccine developers. As of 8 March, over 22.2 million individuals have been vaccinated with a first dose.
At the Comprehensive Spending Review 2020, the Government announced it has made available more than £6 billion in total to develop, manufacture, and procure COVID-19 vaccines. Of that, £733 million in 2021-22 was confirmed to purchase successful vaccines and £128 million was confirmed for the research and development (R&D) of vaccines, as well as their manufacture. Further funding may be allocated from COVID-19 reserves as needed.
On R&D, we have allocated:
At Budget 2021, the Government announced funding of:
On manufacturing,the Government has invested over £300 million to secure and scale-up the UK’s manufacturing capabilities to be able to respond to the pandemic. This includes:
a) Facilities that have come online:
b) Facilities that will come online later this year, to help provide longer-term UK capacity:
In addition to the above, we have also funded the expansion of the Valneva factory in Livingston, Scotland.
Through Help to Grow: Digital, the Government will launch a new online platform this Autumn where businesses can access advice on software that could help them save time and money, and a voucher to reduce the costs of buying that software. Over the next 3 years, 100 000 eligible SMEs could benefit from a voucher providing up to a 50% discount (worth up to £5,000) to adopt approved productivity-enhancing software. The voucher is expected to be available to UK businesses that have more than 5 and fewer than 249 employees and that have been trading for more than 12 months. The programme will launch in Autumn 2021 and eligible businesses are encouraged to register their interest at https://helptogrow.campaign.gov.uk/.
The UK was the first country in the world to procure, authorise, and start a vaccination programme using the Pfizer/BioNTech and Oxford/AstraZeneca vaccines. The Government has secured access to 457 million doses, across eight different vaccine developers. As of 11 March, over 22.8 million individuals have been vaccinated with a first dose in the UK.
At the Spending Review 2020, the Government announced it had made available more than £6 billion in total to develop, manufacture, and procure COVID-19 vaccines. Of that, we confirmed £733 million in 2021-22 to purchase successful vaccines and £128 million for research and development (R&D) and vaccines manufacturing. Further funding will be allocated from the COVID-19 reserve as needed.
For R&D, we have invested:
At Budget 2021, the Government announced funding of:
For manufacturing, the Government has invested over £300 million to secure and scale-up the UK’s manufacturing capabilities to be able to respond to the pandemic. This includes:
a) Facilities that have come online:
b) Facilities that will come online later this year, to help provide longer-term UK capacity:
In addition to the above, we have also funded the expansion of the Valneva factory in Livingston, Scotland.
Enforcement of employment rights remains as important as ever. The Government already spends £35 million a year on state enforcement of employment rights. This Government will always continue to stand behind workers and stamp out unscrupulous practices where they occur.
The industry-led RSC’s work programme is set out on its website https://retailsectorcouncil.co.uk/ along with the minutes of its meetings.
No money has been spent on the Advanced Research and Invention Agency (ARIA). The Government has committed to £800m for ARIA by 2024/25.
The Government has committed to invest £200 million towards a dedicated Life Sciences Investment Programme, to enable the most exciting life sciences companies to scale and grow in the UK.
When the programme is launched by the British Business Bank it will leverage around £400 million of private sector investment, making around £600 million of financing available to the sector over the next 10 years.
UK Research and Innovation (UKRI) recently published a Statement of Opportunities on AI setting out UK’s vision to grow and maintain its international lead in AI research and innovation. UKRI has a key role in facilitating an inclusive and enabling environment for AI research and innovation, including seeking to ensure that professional skills, computing and data analytics capabilities are sufficient to meet the requirements of the UK’s researchers and innovators.
UKRI has been developing a strategy for computing infrastructure that includes people, software and data. Computing is one strand of a successful digital infrastructure ecosystem. Rapid advances in artificial intelligence, and the ability to create ‘digital twins’ of complex systems using High Performance Computing (HPC), have transformative potential for researchers, industry and the public sector. Their large-scale applications requires investing in a computational infrastructure that includes exascale supercomputers to enable the most challenging modelling and simulation problems and the largest AI training challenges. The UK is preparing for the arrival of the exascale era through investment in the UKRI-Met Office ExCALIBUR programme to develop exascale-ready algorithms and software. UKRI’s strategy is for the UK to deploy an exascale supercomputer by 2025.
Additionally, the Government will be investing up to £1.2 billion in new supercomputing infrastructure for the Met Office to provide the UK with world-leading weather and climate science capability.
UK Research and Innovation (UKRI) recently published a Statement of Opportunities on AI setting out UK’s vision to grow and maintain its international lead in AI research and innovation. UKRI has a key role in facilitating an inclusive and enabling environment for AI research and innovation, including seeking to ensure that professional skills, computing and data analytics capabilities are sufficient to meet the requirements of the UK’s researchers and innovators.
UKRI has been developing a strategy for computing infrastructure that includes people, software and data. Computing is one strand of a successful digital infrastructure ecosystem. Rapid advances in artificial intelligence, and the ability to create ‘digital twins’ of complex systems using High Performance Computing (HPC), have transformative potential for researchers, industry and the public sector. Their large-scale applications requires investing in a computational infrastructure that includes exascale supercomputers to enable the most challenging modelling and simulation problems and the largest AI training challenges. The UK is preparing for the arrival of the exascale era through investment in the UKRI-Met Office ExCALIBUR programme to develop exascale-ready algorithms and software. UKRI’s strategy is for the UK to deploy an exascale supercomputer by 2025.
Additionally, the Government will be investing up to £1.2 billion in new supercomputing infrastructure for the Met Office to provide the UK with world-leading weather and climate science capability.
UK Research and Innovation (UKRI) recently published a Statement of Opportunities on AI setting out UK’s vision to grow and maintain its international lead in AI research and innovation. UKRI has a key role in facilitating an inclusive and enabling environment for AI research and innovation, including seeking to ensure that professional skills, computing and data analytics capabilities are sufficient to meet the requirements of the UK’s researchers and innovators.
UKRI has been developing a strategy for computing infrastructure that includes people, software and data. Computing is one strand of a successful digital infrastructure ecosystem. Rapid advances in artificial intelligence, and the ability to create ‘digital twins’ of complex systems using High Performance Computing (HPC), have transformative potential for researchers, industry and the public sector. Their large-scale applications requires investing in a computational infrastructure that includes exascale supercomputers to enable the most challenging modelling and simulation problems and the largest AI training challenges. The UK is preparing for the arrival of the exascale era through investment in the UKRI-Met Office ExCALIBUR programme to develop exascale-ready algorithms and software. UKRI’s strategy is for the UK to deploy an exascale supercomputer by 2025.
Additionally, the Government will be investing up to £1.2 billion in new supercomputing infrastructure for the Met Office to provide the UK with world-leading weather and climate science capability.
The High Performance Computing (HPC) needs of UK researchers will be considered as part of the UK Research and Innovation (UKRI) Digital Infrastructure Strategy. This strategy will also consider access to European and other international computing initiatives. UKRI is investing in UK HPC, such as the new ARCHER2 national facility at the University of Edinburgh (£79m) and the DiRAC HPC provision at Leicester, Durham, Edinburgh, Cambridge, and UCL. The UK has never been part of the European High Performance Computing programme but remains a member of the European PRACE HPC initiative.
The World Health Organisation declared a coronavirus pandemic on 11 March 2020 and we would expect it in due course to declare a move to a post-pandemic period, as it has done previously for the H1N1 influenza pandemic in 2010.
Ministers engage regularly with Amazon, including through the industry-led Retail Sector Council, on a range of topics. The Retail Sector Council has identified employment as one of their priority areas of work. This was discussed at the most recent meeting on 3 February.
The Government has set out its commitment to cement the UK as a world-leading science superpower. Increasing investment in Research and Development will help to achieve that ambition, including investing in new and upgraded high performance computing capability.
As announced in February 2020, the Government will be investing up to £1.2 billion in new supercomputing infrastructure for the Met Office to provide the UK with world-leading weather and climate science capability.
UKRI have also announced an investment of £34 million to expand and upgrade data and digital research infrastructure. This includes advanced analytical capability and enhanced capacity to reveal how COVID-19 has influenced urban mobility, and social and economic activity.
The Office for National Statistics (ONS) publishes data on UK Gross domestic Expenditure on Research and Development (GERD), and the latest release for 2018 stated the private non-profit sector funded £1,860 million, amounting to 5% of total UK GERD of £37,072 million. The equivalent percentages over the previous decade were also about 5%.
The same ONS release gave a figure for GERD funding from overseas of £5,028m in 2018, with £3,250m of this being performed by UK businesses, £1,562m by Higher Education, £172m by Government and UKRI, and £84m by the private non-profit sector.
A more detailed breakdown of the overseas funding of UK business R&D by product group is available in table 12 of the separate ONS release on UK Business Enterprise Research and Development (BERD), while table 23 shows expenditure on R&D performed in overseas-owned UK businesses by product group.
As part of my Rt. Hon. Friend the Prime Minister’s 10 Point Plan for a green industrial revolution, nearly £500m of capital and R&D funding for the Automotive Transformation Fund will be made available in the next four years to build an internationally competitive electric vehicle supply chain in the UK. The funding is the first part of the up to £1 billion committed by the Government to ensure that the UK takes advantage of this once in a generation opportunity. Securing battery cell manufacturing (gigafactories) is a priority, with further targeted investment in motors, drives, power electronics and hydrogen fuel cells. This will not only improve the air quality in our towns and cities, but also help protect existing jobs in the automotive sector, including in our industrial heartlands.
Additionally, the Government and industry have committed around £1 billion over 10 years to 2023 through the Advanced Propulsion Centre to develop low and zero carbon vehicle technologies. The Government is also investing £318m through the Faraday Battery Challenge to develop the next generation of electric batteries, and nearly £80m through the cross-sector Driving the Electric Revolution programme to build the power electronics, motors, and drives supply chain.
The Government has invested over £300 million to secure and scale up the UK’s manufacturing capabilities to be able to respond to the pandemic. This includes:
a) Facilities that have come online:
b) Facilities that will come online later this year, to help provide longer term UK capacity:
In addition to the above, we have also funded the expansion of the Valneva factory in Livingston, Scotland.
UKRI has made over £62 million of financial support available to students most impacted by the pandemic. It is estimated that this funding is available for up to 12,000 students. This is part of a wider package of support where UKRI has already taken significant measures through £180m in costed extensions for research grants, and £334m support for innovative businesses that help support others in the system and their careers, which benefits doctoral students through.
On the requests for additional funding support beyond this, we consider that any additional support to postgraduate researchers must be balanced with the need to support wider research and development funding, including existing commitments. UKRI have recently provided a update on its decision-making in providing support for the research system (Supporting students through the pandemic – UKRI).
I regularly meet with the Minister of State for Universities and with the CEO of UKRI, Professor Dame Ottoline Leyser, to monitor how the pandemic is affecting UKRI-funded PhD students and the wider research system. We will continue to monitor the impacts of COVID-19 and UKRI continues to listen and respond carefully.
We are aware of the enormous pressures that the pandemic has had on doctoral students and their ability to conduct their research. UKRI has made over £62 million of financial support available to students most impacted by the pandemic. It is estimated that this funding is available for up to 12,000 students.
UKRI’s engagement over the summer with universities and supervisors found that many were supporting their students to find creative ways to re-plan their work to enable students to graduate on schedule. In addition, we know that different students have been impacted to different extents.
I regularly meet with my Hon. Friend the Minister of State for Universities and with the CEO of UKRI, Professor Dame Ottoline Leyser, to monitor how the pandemic is affecting UKRI-funded PhD students and the wider research system. We will continue to monitor the impacts of COVID-19 and UKRI continues to listen and respond carefully as the situation evolves.
The Competition Act 1998 prohibits abuse of a dominant position – abusive behaviour can relate to pricing strategies, for example excessive pricing or setting artificially low prices to stifle competition.
The Competition and Markets Authority is responsible for investigating individual and market-wide competition issues in the UK. The Government has ensured that the CMA has significant powers to investigate and act if it finds that companies are behaving anti-competitively in a market.
The Government is committed to ensuring there is an effective products safety system so that only safe products can be sold in the UK. We have some of the most robust product safety requirements in the world. Manufacturers and importers must ensure that products are safe before they are placed on the market. They must monitor the safety of their products in use and take action if a safety issue is identified. Enforcement authorities have powers to take action against manufacturers, importers and distributors of unsafe goods.
The Office for Product Safety and Standards has a memorandum of understanding with the London Fire Brigade and engages regularly with them on issues of product safety.
The Government is committed to ensuring that digital markets are competitive and work for businesses and consumers. In March 2020 we commissioned the Competition and Markets Authority, along with Ofcom and the Information Commissioner’s Office, to advise the Government on how to implement a new pro-competition regime to tackle the market power of dominant digital platforms. The Taskforce published their advice in December 2020 and the Government will respond in due course.
As part of the Integrated Review of Security, Defence, Development and Foreign Policy relevant government departments have worked together to ensure the UK is a force for good across the globe. We will spend more than £10 billion next year alone to fight poverty, tackle climate change and improve global health.
The Government’s commitment to research and innovation is clearly demonstrated through the recently published R&D Roadmap, and the £400m uplift in R&D spending announced in the Spending Review International collaboration is central feature of a healthy and productive R&D sector.
We recently reaffirmed our commitment to doubling UK’s International Climate Finance to £11.6bn in the years 2021-2025. The UK plays a crucial role in addressing the global challenge of climate change, responding to the needs of developing countries.
This information is not held centrally and can only be obtained at disproportionate cost.
BEIS published “The relationship between public and private R&D funding” (BEIS Research Paper Number 2020/010) on 1 July 2020 at https://www.gov.uk/government/publications/research-and-development-relationship-between-public-and-private-funding carried out by Oxford Economics Ltd
They estimated the monetary impact of the long-run leverage rate, suggesting that each £1 of public R&D eventually stimulates between £1.96 and £2.34 of private R&D
The study drew on OECD data for 41 countries from 1961 to 2017 with varying degrees of completeness
The Digital Services Tax is a proportionate tax addressing widely held concerns about the tax paid by digital businesses. Pricing strategies reflect a range of factors and are a matter for businesses. The Government has announced the establishment of a new Digital Markets Unit in the CMA to promote competition in digital markets. We will consult on the powers of this unit in due course.
Since January 2019, BEIS has piloted support to help manufacturing SMEs adopt industrial digital technology to increase their productivity, efficiency and resilience through the Made Smarter North West Pilot, which to date has engaged with more than 1,100 SME manufacturers and more than 150 are receiving intensive support with grant funding. This support is currently only available in the North West of England. Roll out to other parts of England remains under discussion informed by learning from the pilot exercise.
We welcome the strong interest we have seen from local partners in delivering Made Smarter support for adoption of technology in their regions. BEIS has held productive conversations with local partners on their expressions of interest, including in the North East, and I look forward to the continuation of these discussions.
Alongside this support, we are also investing £147m through the Manufacturing Made Smarter Industrial Strategy Challenge Fund. This is accessible to manufacturers of all sizes right across the UK and aims to drive innovation in industrial digital technology solutions. A £20m Challenge Fund competition to support increased digitalisation of supply chains was concluded in October, and Innovation Hubs to help manufacturers explore and test digital technology are being piloted across the country, including through the Centre for Process Innovation at both Darlington and Sedgefield.
The Digital Services Tax is a proportionate tax addressing widely held concerns with the tax paid by digital businesses. The Government cannot comment on individual taxpayers, whose pricing strategies reflect a range of factors and are a matter for businesses.
The Government announced we will publish a new ambitious Places Strategy for R&D in the R&D Roadmap. The Places Strategy will ensure that our research and development system delivers real economic and societal benefits in cities, towns, regions, and devolved nations right across the UK.
We will be stepping up our efforts to foster greater collaboration and co-creation between decision-makers at national, devolved, regional and local levels. We will also be factoring the needs and opportunities of places into our decisions about the R&D system.
Building on strengths and ensuring that all areas experience the benefits of a R&D intensive economy is an important part of the government’s ambition to increase R&D investment across the economy to 2.4% of GDP by 2027.
BEIS and UKRI are engaging widely with industry, civic organisations and the scientific community including universities from across the country to help develop a strategy that responds to the needs of areas and communities across the UK. As part of this we will be considering the recommendations on regional innovation made in the Core Cities UK Universities Declaration.
Looking at innovation more broadly, we have convened an innovation expert group, Chaired by Dr Hayaatun Sillem CBE of the Royal Academy of Engineering, to provide advice to government on the priority actions and opportunities that need to be taken to boost innovation and drive up the UK’s productivity.
This ambitious £450 million fund will support strategic government priorities, build new science capability and support the whole research and innovation ecosystem. This includes the first £50 million towards an £800 million investment by 2024/25 in high-risk, high-payoff research. Further details of how funding will be allocated will be announced in due course.
In the Spending Review last month, my Rt hon Friend Mr Chancellor of the Exchequer said that to cement the UK’s future as a scientific superpower and drive economic growth, the government is investing £14.6 billion in R&D in 2021/22. It will be important to stimulate private sector investment and support public services to get the most out of our excellent research base and to achieve the 2.4% target.
The budget for OneWeb is being allocated to the Department through the supplementary estimates and considered as part of the Comprehensive Spending Review 2020 process.
The Government is investing $500m into OneWeb, and the Department through UKGI, will work closely with the company and other partners to raise additional private investment.
The Government continues to progress plans to establish a new research funding agency as soon as possible. Discussions are ongoing across Government at both official and Ministerial levels to develop and deliver the new agency.
The Government has a high level of ambition for this new blue-skies research funding body, demonstrated by backing it with at least £800 million in funding over its first five years. There has been consideration of various options for how, and where, the body should be established to best meet that ambition.
The Government takes the infringement of IP rights seriously, and delivers a range of work through the UK IPO and other agencies to tackle the sale of counterfeit goods. Following the publication of the 2017 Industrial Strategy the IPO has facilitated a series of roundtables which have been working towards agreements with many of the same sales platforms and rights holder bodies who are signatories to the European Commission MoU. Given this work, and other ongoing domestic interventions, we have no current plans to adopt or formally recognise the European Commission MoU.
The BEIS Energy Innovation Programme supports smart energy by driving innovation in digital and data-enabled technologies for energy management and flexibility, including managing energy demand and creating platforms for trading energy resources. The new £1 billion Net Zero Innovation Portfolio, outlined in the Energy White Paper, will build on this with a theme focussed on disruptive technologies aimed at improving efficiency and optimisation across the energy sector
The R&D Roadmap set out the Government’s vision for research and development. Our goal is to further strengthen science, research and innovation across the UK, making them central to tackling the major challenges we face, including achieving net zero carbon emissions.
The Government has set out plans at Spending Review to cement the UK’s status as a global leader in science and innovation by investing £14.6 billion in R&D in 2021/22. As the custodian of the R&D system, BEIS has been allocated £11.1bn for R&D in 2021/22.
UK Research and Innovation (UKRI) will drive the creation of a Digital Research Infrastructure (DRI) with enhanced environmental sustainability that contributes to the UK government’s commitment to Net Zero. DRI comprises the ecosystem of data, computers, software and skills that are necessary for research and innovation. UKRI is developing a coherent national strategy for DRI that meets the requirements of UKRI’s research and innovation communities across disciplines and that will enable UKRI to take account of the environmental impact of its investments and make decisions that are environmentally sustainable in the long term.
Alongside this strategy, UKRI promotes the AREA framework for responsible innovation, prompting researchers and innovators to Anticipate, Reflect, Engage and Act and so consider aspects such as impact of their work on net zero. Other examples of research related responses include:
The Industrial Strategy Challenge Fund has ten challenges that directly support the goal of achieving Net Zero carbon emissions by 2050 – from reaching net zero in food production, to pioneering greener ways of flying, to developing the world’s first net-zero carbon industrial cluster by 2040. These represent a total of £1.16 billion in government investment. Prior to Covid-19, industry committed to co-invest £1.32 billion across these challenges.
Innovate UK’s priorities and delivery plans for the first part of 2021 are included in UK Research and Innovation (UKRI)’s Corporate Plan for 2020-21. In addition to this, UKRI will publish a one-off delivery plan for Innovate UK that will sit alongside the 2021-22 Corporate Plan, based on its current budget allocation. Publication of this delivery plan is anticipated in the spring of 2021.
Publication of future Delivery Plans for 2022-23 are dependent on future budget allocations for Innovate UK.
The postal service plays an important role in helping to mitigate the impacts of coronavirus on individuals, families, and businesses up and down the country.
Royal Mail, a private company, has well-established contingency plans to mitigate disruption to postal services overseen by Ofcom, the independent regulator. The Government is not involved in the day-to-day operations of the company.
We have made clear in the R&D Roadmap that we aim to maintain a close and friendly relationship with our European partners, seeking to agree a fair and balanced deal for participation in EU R&D schemes. Negotiations remain ongoing and we will make a final decision once it is clear whether such terms can be reached.
The Government committed in the R&D Roadmap to reaching 2.4% of GDP being spent on R&D across the UK economy by 2027. Investment in R&D will include funding for any continued participation in EU research and innovation Programmes or replacement schemes. The outcome of the Spending Review does not presuppose the outcome of negotiations with the EU.
No decision has been made on whether the UK will associate to upcoming EU R&D Programmes as negotiations remain ongoing. Whatever the outcome of negotiations, this government is committed to maintaining and enhancing the UK’s position at the forefront of global science collaboration.
We have made clear in the R&D Roadmap that we aim to maintain a close and friendly relationship with our European partners, seeking to agree a fair and balanced deal for participation in EU R&D schemes. We will make a final decision once it is clear whether such terms can be reached. If we do not associate to Horizon Europe, the Government will implement ambitious alternatives as quickly as possible from January 2021 and address the funding gap.
The Government has committed £14.6bn to R&D next year. This funding will support the life sciences sector within which Medical Research Charities operate alongside other research areas.
No, we do not plan to change the 2.4% target and remain committed to increasing UK investment in R&D to 2.4% of GDP by 2027.
Yes, the £6 billion announced in the Spending Review 2020 for development and procurement of vaccines is inclusive of existing covid-19 vaccine procurement contracts.
Section 790ZG of the Companies Act 2006 provides a route for people to apply for their personal details to be withheld from the public register of people with significant control information, where the publication of the person’s link to the company would place the person or their immediate family at risk of harm.
The information is held securely by Companies House and can be accessed by specified public authorities on request. The Gambling Commission are one of the specified public authorities listed under schedule 3 of The Register of People with Significant Control Regulations 2016.
The Department for Business, Energy and Industrial Strategy and the Department for Health and Social Care regularly discuss the impacts of Covid-19 on charity-funded research with the Association of Medical Research Charities, and we are continuing to engage with them.
The latest data published by the Office for National Statistics is for 2018, showing UK Gross Expenditure on R&D at 1.71% of GDP, an increase on the previous year’s figure. ONS plans to release data for 2019 in spring 2021.
The Government has set out plans at Spending Review to cement the UK’s status as a global leader in science and innovation by investing £14.6 billion in R&D in 2021/22.
Private investment is a major part of UK R&D spend and leveraging this investment will be key to achieving the 2.4% target. In our R&D Roadmap, published in July 2020, we set out our priorities for boosting R&D across the economy.
The Government has set out plans at Spending Review to cement the UK’s status as a global leader in science and innovation by investing £14.6 billion in R&D in 2021/22. This investment supports our commitments set out in the R&D Roadmap and helps consolidate our position as a science superpower as we build towards UK R&D investment of 2.4% of GDP by 2027.
Leveraging investment from the private sector that we will reach the target. By increasing public investment in R&D, we will attract further private sector investment. On average, £1 of public investment in R&D eventually leverages around £2 of additional private sector investment.
The UK already has world-class science and research and is ranked as one of the most innovative countries in the world, investing 1.7% of GDP in 2018. The first figures reflecting the proportion of GDP invested in R&D in 2020 are expected to be released in Spring 2022.
In response to the pandemic, the Government has put in place an unprecedented package of support for businesses, including job support schemes, over £60 billion in grants and loans, and cuts to VAT and business rates relief. The Government has also introduced temporary measures in the Corporate Insolvency and Governance Act to support businesses to keep going through the pandemic, including restricting the use of statutory demands and company winding-up petitions, and suspending the wrongful trading provisions.
The Office for Budget Responsibility (OBR) judged, in its recent Economic and Fiscal Outlook, that these measures, together with forbearance on the part of creditors, have helped to reduce the number of insolvencies so far this year by almost a third compared to 2019. The Government has recently extended its package of support measures through to March 2021 to continue to support businesses as the economy emerges from the pandemic.
Due to commercial sensitivities, the Government will not be able to publish the advice used by my Rt. Hon. Friend the Secretary of State in making the decision to purchase OneWeb.
I refer the Hon. Member to the answer I gave her on 27th October 2020 to Question 106333.
Negotiations to associate to the EU R&D programmes, Horizon Europe and Euratom R&T, are ongoing. If we do not associate to Horizon Europe, we have committed to meet any funding shortfalls and put in place alternative schemes. In that case, any assessment of the funding gap would need to take account of the outcome of discussions on the EU budget and the Horizon Europe Programme regulations, which are still being finalised.
UK funding for EU programmes, or for alternatives would also be subject to allocations at the Spending Review.
As a steward of the research and innovation system, UKRI’s ambition is to nurture and support its communities recognising and valuing everyone in it. Evidence, diversity data and insight underpin UKRI’s approach to enable a dynamic, diverse and inclusive research and innovation system in the UK that is an integral part of society, giving everyone the opportunity to participate and to benefit.
UKRI are continuously working to improve our appointments process for advisory and peer review bodies to encourage a more diverse set of applicants and proactively include statements in adverts to increase representation for those that are under-represented on our councils and advisory boards. Additionally, within peer review UKRI aim to select as broad an expertise as possible, in terms of disciplinary background, career paths, ethnicity, diversity and inclusion, as well as host organisation.
UKRI undertake Equality Impact Assessments for our funding opportunities. UKRI have reviewed and made changes to their peer review processes in recent years to safeguard the process, including principles of fair peer review (https://www.ukri.org/wp-content/uploads/2020/10/UKRI-07102020-PrinciplesofAssessmentandDecisionMaking.pdf), and providing training to reduce the likelihood of bias in decision making.
UKRI continue to explore the use of new tools to broaden the pool of potential people to act as reviewers. The Engineering and Physical Sciences Research Council (EPSRC) Inclusion Matters portfolio of 11 EDI projects includes work looking at the peer review process.
The updated Notice published on 6th November on the Sustaining University Research Expertise Fund (SURE) set out further details on the Fund, including the formula for calculating allocations, conditions of funding and next steps. This included confirmation that these losses from international student fees is being calculated. Calculations would be made using forecast data as at 30 October 2020, provided through the recent interim financial data collection exercise undertaken by the Office for Students, and equivalent processes in Wales and Scotland, compared against academic year (AY) 2018-19 baseline data.
We are grateful to the British Business Bank for launching the ‘Alone together: Entrepreneurship and diversity in the UK’ report. The report is published in full and we are working with the British Business Bank to understand how to better address the challenges faced by BAME and women-led businesses. Government always welcomes input to ensure our support benefits these communities.
A diverse and inclusive finance ecosystem is good for entrepreneurs, companies, investors, and the society as a whole. Therefore, all of the Government’s business support schemes are open to eligible businesses from all regions and backgrounds, including BAME and female entrepreneurs. The Government will continue to monitor the implementation and take up of the schemes, working with investors, lenders, representative groups across the industry and the British Business Bank.
We are working with the private sector to deliver the eight initiatives of the Rose Review. Great progress has been made over the past year with NatWest and Be the Business jointly launching the Rose Review Female Entrepreneurs Mentoring Programme soon on 27 October.
More widely, the Government has set an ambition of 20,000 start-up loans being issued to Black and Minority Ethnic applicants by the end of this parliament. Of all the start-up loans issued up to September 2020, 16,159 loans (21% of lending) was issued to entrepreneurs from a BAME background and around 30,000 loans, worth over £239m, were issued to female entrepreneurs.
The Department’s Ministerial team is also actively engaging with entrepreneurs from the BAME business community to better understand their concerns, including access to finance, and has undertaken 10 engagements since March 2020.
At the 2020 Budget, my Rt. Hon. Friend Mr Chancellor of the Exchequer announced the Government’s ambitious commitment to increase public spending in research and development to £22 billion by 24/25, putting the UK on track to reach 2.4% of GDP being spent on research and development across the UK economy by 2027.
In order to prioritise the response to Covid-19, and our focus on supporting jobs, the Chancellor and my Rt. Hon. Friend the Prime Minister have decided to conduct a one-year Spending Review, setting departments’ resource and capital budgets for 2021-22, and Devolved Administrations’ block grants for the same period. This Spending Review will be delivered on 25th November.
Government recognises the importance of having a research system that values and recognises all and is committed to addressing under-representation and inequalities including those around gender, disability and ethnicity. UKRI publishes comprehensive annual data on success rates for grant applications, fellowships and PhD starts for these characteristics and has taken positive steps to increase diversity in the peer review processes and advisory groups that decide on these.
To maximise on the economic and environmental opportunities of a transition to zero emission vehicles, the UK Government is supporting the creation of a circular economy for electric vehicle batteries.
The future demand for the recycling and disposal of lithium ion batteries and the UK skills base in this area has been assessed by Government and research into battery re-cycling, and the large scale industrialisation, is currently being undertaken.
To support this vital work, we have committed £318m to the Faraday Battery Challenge to fund the research, development and scale-up of world-leading battery technology in the UK. The innovation strand of the Faraday Battery Challenge is supporting several business-led collaborative R&D projects on reuse and recycle of electric vehicle batteries.
Policy is being formulated based on this research and Government is committed to building on the Faraday research programmes to ensure that we meet the skills and demand required to support this growing industry.
The Government has funded early clinical trials for the Imperial vaccine which began in June 2020 and continue.
The £18.5 million for further large scale studies for 2.5 million people has not yet been disbursed, as those studies cannot be undertaken until the ongoing phase 1 clinical trials, future phase 2 efficacy trials and other criteria have proven successful and regulatory approvals have been secured for human deployment of the vaccine.
Any further investment decisions will be made in due course as necessary.
The 18 month UK Global Navigation Satellite System Programme successfully concluded its work to develop outline proposals for a conventional satellite navigation system in September. £92m was originally allocated for the UK GNSS Programme and work has concluded successfully under budget. Much of the work was covered by Non-Disclosure Agreements and, for reasons of both commercial and national security sensitivities, it is not possible to offer a detailed breakdown of that spending for both inside and outside the UK.
Work completed by the UK Space Agency so far has developed cutting edge British expertise in areas such as spacecraft and antenna design, satellite and ground control systems, systems engineering and simulation, which have wider applications across the space sector, in addition to supporting specialist UK jobs and industrial GNSS capability.
The new Space Based PNT Programme will carry forward this work to consider newer, more innovative ideas of delivering global ‘sat nav’ and secure satellite services to meet public, government and industry needs.
The 18 month UK Global Navigation Satellite System Programme successfully concluded its work to develop outline proposals for a conventional satellite navigation system in September. £92m was originally allocated for the UK GNSS Programme and work has concluded successfully under budget. Much of the work was covered by Non-Disclosure Agreements and, for reasons of both commercial and national security sensitivities, it is not possible to offer a detailed breakdown of that spending for both inside and outside the UK.
Work completed by the UK Space Agency so far has developed cutting edge British expertise in areas such as spacecraft and antenna design, satellite and ground control systems, systems engineering and simulation, which have wider applications across the space sector, in addition to supporting specialist UK jobs and industrial GNSS capability.
The new Space Based PNT Programme will carry forward this work to consider newer, more innovative ideas of delivering global ‘sat nav’ and secure satellite services to meet public, government and industry needs.
The Government funds research and clinical trials through UK Research and Innovation (UKRI) and the National Institute for Health Research (NIHR), and we have put a large focus on research into COVID-19 to tackle the immediate crisis.
The NIHR baseline budget for 2020/21 is set at £1,090 million excluding Official Development Assistance funding. In addition, there will be a number of in-year budget adjustments/transfers and funding contributions from the Devolved Administrations and other funders that have yet to be finalised but will at current estimates exceed £50 million. NIHR expects to spend its budget in full and a significant proportion of this spend will be on funding or supporting clinical trials funded by other research funders
However, the Government’s long-term objectives for R&D are clear: to invest in the science and research that will deliver economic growth and societal benefits across the UK for decades to come, and to build the foundations for the new industries of tomorrow.
The Research and Development Roadmap published by BEIS this summer set out the UK’s vision and ambition for science, research and innovation. To realise this ambition we need to ensure all people, regardless of background, have the opportunity to study STEM subjects and aspire to careers in science and engineering. The forthcoming People and Culture Strategy for Research will set out how Government will support the sector in developing a research culture that is welcoming to those from under-represented groups.
The timings of the not for profit price commitment are for the two parties involved, AstraZeneca and the University of Oxford to agree.
The NHS is preparing for the initial deployment of a safe, effective COVID-19 vaccine as soon as possible.
The Small Business Grants Fund (SBGF), the Retail, Hospitality and Leisure Grants Fund (RHLGF) and the Local Authority Discretionary Grants Fund (LADGF) were part of an unprecedented package of support for businesses in recognition of the disruption caused by Covid-19. My department worked with HM Treasury on the design and delivery of these funds.
We have been clear with local authorities throughout that any unspent funds would need to be returned to the Exchequer. The schemes closed on 28th August 2020, with all payments made by 30th Sept. Local authorities have now received guidance on the reconciliation process.
As of 20th September, 1,260,940 applications have been approved for Bounce Back loans, at a value of £38.02bn.
The Bounce Back Loan Scheme is currently being delivered through 28 accredited lenders, including several non-banks and alternative lenders. If a business is unable to access the scheme because their bank is not a participant or is unable to process their application, they may also consider approaching other Scheme accredited providers.
Several lenders are allowing applications from new customers. The Government have always made clear to lenders that they should open to new customers as soon as it is operationally possible for them to do so.
The installation of automated sorting machines is an operational matter for Royal Mail, a private company.
The Government recognises the importance of research and development (R&D) in helping to transform the steel sector so that it can play a vital role within our modern Industrial Strategy.
Agreement has been reached that UK participants engaged in ongoing Research Fund for Coal and Steel (RFCS) projects will continue to be funded until completion. However, the Commission has informed UK participants in consortia that are bidding for funding this year, that they will not be eligible to receive RFCS funding. This is because the resulting grant contracts are due to be signed in April to June 2021, after the end of the transition period established in the Withdrawal Agreement.
Leaving the EU provides us with the opportunity to focus our investment on our own priorities. This includes the Government’s commitment to invest £22 billion in R&D by 2024/2025, which is a record increase in R&D spending. We have also announced a £250 million investment towards a Clean Steel Fund, complemented by a £100 million Low Carbon Hydrogen Production Fund, to support decarbonisation and make the most of the clean growth opportunities in steel.
The Government is committed to keeping the UK at the forefront of globally collaborative research and innovation. If we do not associate to Horizon Europe, we will implement alternatives as quickly as possible from January 2021 and address the funding gap. The Government has committed to raising public investment in R&D to £22 billion per year by 2024/25. This will include funding for any continued participation in EU science programmes or EU replacement schemes.
The amount of grant funding provided under the Sustaining University Research Excellence (SURE) fund will depend on income losses which at this point remain unclear - each university’s allocation is the lower of 80% of losses in international student income or the value of non-public research funding.
The Government is implementing the Challenge on Dementia 2020 published in February 2015 to make sure that dementia care, support, awareness and research are transformed by 2020. The Challenge is available at: https://www.gov.uk/government/publications/prime-ministers-challenge-on-dementia-2020
We are updating the strategy and will be setting out our plans on dementia for England for future years in due course.
The Department for Business, Energy and Industrial Strategy and the Department of Health and Social Care have spent £341 million between 2015 and by March 2019, funding for 2020 is unavailable.
The UK Government has secured access to two vaccines being manufactured in the UK:
The UK Government has also secured access to the vaccine being developed by Valneva, who are based in France but will manufacture the vaccine in Scotland.
The Vaccines Taskforce, in collaboration with the Department for Health & Social Care and Public Health England, are working to ensure supply chain resilience for the manufacture and delivery of all potential COVID-19 vaccine candidates, including those where UK research institutions are involved.
The Independent Review of the Financial Reporting Council (FRC) recommended that consideration be given to the case for a strengthened internal control framework, learning any relevant lessons from operation of the Sarbanes-Oxley regime in the US. Sir Donald Brydon’s review of the quality and effectiveness of audit also made suggestions for enhancing the role of the board and the auditor in a strengthened internal control system.
The Government will publish and seek views on its proposals on audit reform in due course, including in response to these particular recommendations. The Government has been working closely with the FRC in developing these proposals.